{"title": "La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)", "author": null, "url": "https://www.colfarma.info/colfarma/la-biblioteca-le-brinda-un-dossier-informativo-actualizado-sobre-coronavirus-covid-19/", "hostname": "colfarma.info", "description": null, "sitename": "colfarma.info", "date": "2020-04-08", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Sociedades cient\u00edficas: Recursos\nResumen de recomendaciones vigentes para la Campa\u00f1a Nacional de Vacunaci\u00f3n contra la COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2023-06/actualizacion-lt-covid.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-06/actualizacion-lt-covid.pdf)\nDosis de refuerzo contra COVID-19 \u2013 Actualizaci\u00f3n\n[https://bancos.salud.gob.ar/sites/default/files/2023-05/memo-actualizacion-refuerzo-covid-19_03-5-2023.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-05/memo-actualizacion-refuerzo-covid-19_03-5-2023.pdf)\nManual del vacunador de Pfizer Bivariante\n[https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf)\nOPS: ESAVI contra la COVID-19 y otras actualizaciones (abril 2023)\n[http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2023/05/Actualizacio%C3%ACn-perio%C3%ACdica-ESAVI-vacunas-COVID-19-ABRIL-2023.pdf](http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2023/05/Actualizacio%C3%ACn-perio%C3%ACdica-ESAVI-vacunas-COVID-19-ABRIL-2023.pdf)\nMonitor P\u00fablico de Vacunaci\u00f3n en tiempo real. Argentina\n[https://www.argentina.gob.ar/coronavirus/vacuna/aplicadas](https://www.argentina.gob.ar/coronavirus/vacuna/aplicadas)\nManual para Vacunadores Vacuna Sputnik Light\n[https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-sputnik-light.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-sputnik-light.pdf)\nManual para Vacunadores Vacuna SPIKEVAX BIVARIANTE, Original/Omicron BA.4-5 (Vacuna COVID-19 ARNm, Moderna)\n[https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-moderna-bivariante.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-moderna-bivariante.pdf)\nMemor\u00e1ndum | Refuerzos Vacunaci\u00f3n contra COVID-19 en ni\u00f1os, ni\u00f1as y adolescentes\n[https://bancos.salud.gob.ar/sites/default/files/2023-01/refuerzos-vacunacion-contra-COVID-19-en-ni%C3%B1os-ni%C3%B1as-adolescentes.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-01/refuerzos-vacunacion-contra-COVID-19-en-ni%C3%B1os-ni%C3%B1as-adolescentes.pdf)\nMemor\u00e1ndum | Uso de vacuna contra COVID-19 formulaci\u00f3n pedi\u00e1trica del laboratorio Moderna\n[https://bancos.salud.gob.ar/sites/default/files/2023-01/uso-de-vacuna-contra-COVID-19-formulacion-pediatrica-del-laboratorio-moderna.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-01/uso-de-vacuna-contra-COVID-19-formulacion-pediatrica-del-laboratorio-moderna.pdf)\nManual del vacunador de Pfizer Bivariante\n[https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf](https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf)\nSeguimiento de las variantes del SARS-CoV-2\n[https://www.who.int/es/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants](https://www.who.int/es/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants)\nAn\u00e1lisis de la vacunaci\u00f3n contra la COVID-19 en la Regi\u00f3n de las Am\u00e9ricas. Desglose por sexo y edad y en subpoblaciones seleccionadas\n[https://iris.paho.org/handle/10665.2/56734](https://iris.paho.org/handle/10665.2/56734)\nPrograma de optimizaci\u00f3n del uso de antimicrobianos durante la pandemia de COVID-19\n[https://www.medicinabuenosaires.com/revistas/vol82-22/n5/641.pdf](https://www.medicinabuenosaires.com/revistas/vol82-22/n5/641.pdf)\nSalud recuerda la importancia de aplicar los refuerzos de vacuna contra COVID-19\n[https://www.argentina.gob.ar/noticias/salud-recuerda-la-importancia-de-aplicar-los-refuerzos-de-vacuna-contra-covid-19](https://www.argentina.gob.ar/noticias/salud-recuerda-la-importancia-de-aplicar-los-refuerzos-de-vacuna-contra-covid-19)\nMemo: Tercer refuerzo en personas de 18 a\u00f1os o m\u00e1s\n[https://bancos.salud.gob.ar/sites/default/files/2022-12/Tercer%20refuerzo%20en%20personas%20de%2018%20a%C3%B1os%20o%20m%C3%A1s.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-12/Tercer%20refuerzo%20en%20personas%20de%2018%20a%C3%B1os%20o%20m%C3%A1s.pdf)\nFrente a la suba de casos de COVID-19, Salud recomienda a la poblaci\u00f3n aplicarse los refuerzos de vacunas\n[https://www.argentina.gob.ar/noticias/frente-la-suba-de-casos-de-covid-19-salud-recomienda-la-poblacion-aplicarse-los-refuerzos](https://www.argentina.gob.ar/noticias/frente-la-suba-de-casos-de-covid-19-salud-recomienda-la-poblacion-aplicarse-los-refuerzos)\n19\u00b0 Informe de seguridad en vacunas\n[https://bancos.salud.gob.ar/sites/default/files/2022-12/informe-19-noviembre-2022.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-12/informe-19-noviembre-2022.pdf)\nDudas generales sobre la vacunaci\u00f3n contra la COVID-19. Informaci\u00f3n para el paciente\n[https://iris.paho.org/bitstream/handle/10665.2/56512/OPSFPLIMCOVID190032_spa.pdf?sequence=1&isAllowed=y](https://iris.paho.org/bitstream/handle/10665.2/56512/OPSFPLIMCOVID190032_spa.pdf?sequence=1&isAllowed=y)\nPrevenci\u00f3n y Control de COVID-19 y otras Enfermedades Respiratorias Agudas en Residencias de Personas Mayores\n[https://portal-coronavirus.gba.gob.ar/docs/instituciones/Recomendaciones-para-residencias-de-personas-mayores.pdf](https://portal-coronavirus.gba.gob.ar/docs/instituciones/Recomendaciones-para-residencias-de-personas-mayores.pdf)\nVacunas de ARNm (Comirnaty y Spikevax) frente a la COVID-19 y riesgo de sangrado menstrual abundante\n[https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2022/docs/NI_MUH_FV_07_2022-trastonos-menstruales.pdf](https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2022/docs/NI_MUH_FV_07_2022-trastonos-menstruales.pdf)\nEVUSHELD\u00ae: tixagevimab/cilgavimab para el tratamiento de la COVID-19\n[http://www.navarra.es/NR/rdonlyres/6EAA15A8-75D9-4C43-B218-98D590FC247D/483026/FichaEvusheldTRATAMIENTO.pdf](http://www.navarra.es/NR/rdonlyres/6EAA15A8-75D9-4C43-B218-98D590FC247D/483026/FichaEvusheldTRATAMIENTO.pdf)\nII Informe sobre el impacto de la pandemia por SARS-CoV-2 en las coberturas nacionales de vacunaci\u00f3n de Argentina\n[https://bancos.salud.gob.ar/sites/default/files/2022-11/II_informe_impacto_pandemia_sobre_coberturas_vacunacion.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-11/II_informe_impacto_pandemia_sobre_coberturas_vacunacion.pdf)\nLineamientos T\u00e9cnicos | Tercer refuerzo\n[https://bancos.salud.gob.ar/sites/default/files/2022-11/lineamientos-tecnicos-tercer-refuerzo.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-11/lineamientos-tecnicos-tercer-refuerzo.pdf)\nReacciones adversas a medicamentos utilizados para la COVID-19 en cinco pa\u00edses de Am\u00e9rica Latina\n[https://iris.paho.org/bitstream/handle/10665.2/56484/v46e1782022.pdf?sequence=1&isAllowed=y](https://iris.paho.org/bitstream/handle/10665.2/56484/v46e1782022.pdf?sequence=1&isAllowed=y)\nPosible impacto de la COVID-19 en el aumento de casos en Espa\u00f1a de enfermedad neumoc\u00f3cica por cepas resistentes a antibi\u00f3ticos\n[https://www.univadis.es/viewarticle/posible-impacto-de-la-covid-19-en-el-aumento-de-casos-en-espana-de-enfermedad-neumococica-por-cepas-resistentes-a-antibioticos-771372](https://www.univadis.es/viewarticle/posible-impacto-de-la-covid-19-en-el-aumento-de-casos-en-espana-de-enfermedad-neumococica-por-cepas-resistentes-a-antibioticos-771372)\nComprueban que las mujeres vacunadas contra el COVID-19 transfieren protecci\u00f3n a sus hijos a trav\u00e9s de la leche materna, un hallazgo clave para los menores de 6 meses\n[https://www.agenciacyta.org.ar/2022/10/comprueban-que-las-mujeres-vacunadas-contra-el-covid-19-transfieren-proteccion-a-sus-hijos-a-traves-de-la-leche-materna-un-hallazgo-clave-para-los-menores-de-6-meses/](https://www.agenciacyta.org.ar/2022/10/comprueban-que-las-mujeres-vacunadas-contra-el-covid-19-transfieren-proteccion-a-sus-hijos-a-traves-de-la-leche-materna-un-hallazgo-clave-para-los-menores-de-6-meses/)\nAndaluc\u00eda: Preguntas frecuentes para Profesionales: Vacunaci\u00f3n frente a al COVID-19\n[https://www.andavac.es/campanas/covid/informacion-para-profesionales/preguntas-frecuentes/](https://www.andavac.es/campanas/covid/informacion-para-profesionales/preguntas-frecuentes/)\nCOVID-19. Informe n\u00b0 80 julio 2022 OPS\n[https://iris.paho.org/bitstream/handle/10665.2/56298/COVID-19SitRep80_spa.pdf?sequence=1&isAllowed=y](https://iris.paho.org/bitstream/handle/10665.2/56298/COVID-19SitRep80_spa.pdf?sequence=1&isAllowed=y)\nEventos adversos de inter\u00e9s especial y eventos adversos supuestamente atribuibles a la vacunaci\u00f3n o inmunizaci\u00f3n durante la introducci\u00f3n de las vacunas contra la COVID-19. Segunda edici\u00f3n\n[https://iris.paho.org/handle/10665.2/56207](https://iris.paho.org/handle/10665.2/56207)\nLos pediatras de Atenci\u00f3n Primaria recomiendan tomar precauciones frente a virus respiratorios en la primera vuelta al cole sin medidas anti-covid. Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP)\n[https://www.aepap.org/sites/default/files/noticia/archivos-adjuntos/np_vuelta_al_cole_-_precauciones_virus.pdf](https://www.aepap.org/sites/default/files/noticia/archivos-adjuntos/np_vuelta_al_cole_-_precauciones_virus.pdf)\nOptimizaci\u00f3n de la vacunaci\u00f3n mediante la coadministraci\u00f3n de vacunas contra la gripe y el Covid-19: orientaci\u00f3n para farmac\u00e9uticos (FIP) (en ingl\u00e9s)\n[https://www.fip.org/file/5227](https://www.fip.org/file/5227)\nCriterios para valorar la administraci\u00f3n de las nuevas alternativas terap\u00e9uticas antivirales frente a la infecci\u00f3n por SARS-CoV-2\n[https://www.aemps.gob.es/medicamentos-de-uso-humano/acceso-a-medicamentos-en-situaciones-especiales/criterios-para-valorar-la-administracion-de-las-nuevas-alternativas-terapeuticas-](https://www.aemps.gob.es/medicamentos-de-uso-humano/acceso-a-medicamentos-en-situaciones-especiales/criterios-para-valorar-la-administracion-de-las-nuevas-alternativas-terapeuticas-antivirales-frente-a-la-infeccion-por-sars-cov-2/)\nPrograma de optimizaci\u00f3n del uso de antimicrobianos durante la pandemia de covid-19\n[https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7779.pdf](https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7779.pdf)\nSeguridad y efectividad de vacuna COVID-19 SPUTNIK V en pacientes en di\u00e1lisis\n[http://www.nefrologiaargentina.org.ar/numeros/2022/volumen20_1/PremioMiatello.pdf](http://www.nefrologiaargentina.org.ar/numeros/2022/volumen20_1/PremioMiatello.pdf)\nARGENVAC ser\u00e1 una herramienta para convivir con el virus de COVID-19\n[http://solp-admin.diper-it.com/api/uploads/magazinearticles/ARGENVAC-sera-una-herramienta-para-convivir-con-el-virus-de-COVID-19/Preview_Revista_SOLP_62_Docena.pdf](http://solp-admin.diper-it.com/api/uploads/magazinearticles/ARGENVAC-sera-una-herramienta-para-convivir-con-el-virus-de-COVID-19/Preview_Revista_SOLP_62_Docena.pdf)\nVacunaci\u00f3n contra COVID-19 en ni\u00f1os y ni\u00f1as de 6 meses a 3 a\u00f1os y refuerzo de 3 y 4 a\u00f1os de edad. Sociedad Argentina de Pediatr\u00eda\n[https://www.sap.org.ar/uploads/documentos/documentos_vacunacion-contra-covid-19-en-ninos-y-ninas-de-6-meses-a-3-anos-y-refuerzo-de-3-y-4-anos-de-edad-306.pdf](https://www.sap.org.ar/uploads/documentos/documentos_vacunacion-contra-covid-19-en-ninos-y-ninas-de-6-meses-a-3-anos-y-refuerzo-de-3-y-4-anos-de-edad-306.pdf)\nManual del Vacunador | Lineamientos T\u00e9cnicos Vacunaci\u00f3n con Moderna de 6 meses a 3 a\u00f1os y refuerzo de 3 y 4 a\u00f1os\n[https://bancos.salud.gob.ar/sites/default/files/2022-07/manual-vacunador-moderna-3-a-5-anos.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-07/manual-vacunador-moderna-3-a-5-anos.pdf)\nActualizaciones basadas en evidencia COVID-19\n[https://www.argentina.gob.ar/salud/conetec/actualizaciones](https://www.argentina.gob.ar/salud/conetec/actualizaciones)\nCOVID y rellenos faciales \u00bfrealmente debemos preocuparnos?\n[https://www.actasdermo.org/es-pdf-S0001731022004689](https://www.actasdermo.org/es-pdf-S0001731022004689)\nPreguntas frecuentes sobre la vacuna contra COVID-19\n[https://www.argentina.gob.ar/coronavirus/vacuna/preguntas-frecuentes](https://www.argentina.gob.ar/coronavirus/vacuna/preguntas-frecuentes)\nGlomerulonefritis por cambios m\u00ednimos post vacuna COVID-19 AstraZeneca\n[https://www.revistarenal.org.ar/index.php/rndt/article/view/758/1213](https://www.revistarenal.org.ar/index.php/rndt/article/view/758/1213)\nDeclaraci\u00f3n para los profesionales de la salud: c\u00f3mo se regulan las vacunas contra la COVID-19 para garantizar que son seguras y eficaces\n[https://www.who.int/es/news/item/11-06-2021-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness](https://www.who.int/es/news/item/11-06-2021-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness)\nLineamientos T\u00e9cnicos | Primer refuerzo en ni\u00f1os y ni\u00f1as de 5 a 11 a\u00f1os\n[https://bancos.salud.gob.ar/sites/default/files/2022-05/lineamientos-primer-refuerzo-personas-edad-5-11.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-05/lineamientos-primer-refuerzo-personas-edad-5-11.pdf)\nEvidencia sobre las vacunas para COVID-19 en ni\u00f1as, ni\u00f1os y adolescentes\n[https://www.evidencia.org/index.php/Evidencia/article/view/6997/4660](https://www.evidencia.org/index.php/Evidencia/article/view/6997/4660)\nManual del Vacunador | Vacuna MODERNA para uso pedi\u00e1trico de 6 a 11 a\u00f1os\n[https://bancos.salud.gob.ar/sites/default/files/2022-04/manual-vacunador-moderna-desde-6-anos.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-04/manual-vacunador-moderna-desde-6-anos.pdf)\nManual del Vacunador | Segundo Refuerzo COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2022-04/covid-19-lineamientos-tecnicos-segundo-refuerzo.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-04/covid-19-lineamientos-tecnicos-segundo-refuerzo.pdf)\nEl uso de corticoides inhalados para el tratamiento de COVID-19 podr\u00eda disminuir el riesgo de hospitalizaci\u00f3n o muerte y el tiempo de resoluci\u00f3n de s\u00edntomas\n[https://www.evidencia.org/index.php/Evidencia/article/view/7007/4676](https://www.evidencia.org/index.php/Evidencia/article/view/7007/4676)\nMemor\u00e1ndum | Consideraciones para la habilitaci\u00f3n de vacunaci\u00f3n contra Covid-19 para viajeros\n[https://bancos.salud.gob.ar/sites/default/files/2022-03/memorandum_17-03_Vacunas_exterior.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-03/memorandum_17-03_Vacunas_exterior.pdf)\nBaricitinib para el tratamiento de pacientes con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n15-baricitinib.pdf](https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n15-baricitinib.pdf)\nCOVID-19 plant-based vaccines\n[https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/plant-based.html](https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/plant-based.html)\nLa vacuna de ARN BNT162b2 frente a la COVID-19 parece segura y eficaz en ni\u00f1os mayores de 4 a\u00f1os\n[https://evidenciasenpediatria.es/files/41-14112-RUTA/5_ACV_Vacuna_COVID.pdf](https://evidenciasenpediatria.es/files/41-14112-RUTA/5_ACV_Vacuna_COVID.pdf)\nManual del vacunador. Vacuna Comirnaty de Pfizer-BioNTech pedi\u00e1trica de 5 a 11 a\u00f1os\n[https://bancos.salud.gob.ar/sites/default/files/2022-03/manual-pfizer-pediatrica.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-03/manual-pfizer-pediatrica.pdf)\nActualizaci\u00f3n de los Lineamientos T\u00e9cnicos | Resumen de recomendaciones vigentes para la Campa\u00f1a Nacional de Vacunaci\u00f3n contra la COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2022-02/lineamientos-tecnicos_unificado-covid19-2022.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-02/lineamientos-tecnicos_unificado-covid19-2022.pdf)\nPer\u00edodo de detecci\u00f3n de SARS-CoV2 a trav\u00e9s de PCR y Test de ant\u00edgenos\n[https://gacetamedica.com/wp-content/uploads/2021/02/Periodo-de-detecci%C3%B3n-de-SARS-CoV-2-a-trav%C3%A9s-de-PCR-y-Test-de-ant%C3%ADgenos-2.pdf](https://gacetamedica.com/wp-content/uploads/2021/02/Periodo-de-detecci%C3%B3n-de-SARS-CoV-2-a-trav%C3%A9s-de-PCR-y-Test-de-ant%C3%ADgenos-2.pdf)\nNuevas condiciones de aislamiento\n[https://bancos.salud.gob.ar/sites/default/files/2022-01/nuevas-condiciones-aislamiento-covid-19_2022-01-18.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-01/nuevas-condiciones-aislamiento-covid-19_2022-01-18.pdf)\nRecomendaci\u00f3n de vacunaci\u00f3n contra la COVID-19 en personas gestantes\n[https://bancos.salud.gob.ar/sites/default/files/2022-01/memo-personas-gestantes-11-01-22.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-01/memo-personas-gestantes-11-01-22.pdf)\nAdecuaci\u00f3n de las medidas para contactos estrechos de COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2022-01/comunicacion-medidas-ce.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-01/comunicacion-medidas-ce.pdf)\nAlgoritmos de manejo de casos, contactos estrechos y personas sintom\u00e1ticas\n[https://bancos.salud.gob.ar/sites/default/files/2022-01/algoritmos-definiciones-covid19-2022.pdf](https://bancos.salud.gob.ar/sites/default/files/2022-01/algoritmos-definiciones-covid19-2022.pdf)\nMemor\u00e1ndum | \u00abRecomendaci\u00f3n de intervalo de dosis de refuerzo en personal de salud y mayores de 60 a\u00f1os\u00bb\n[https://bancos.salud.gob.ar/sites/default/files/2021-12/memo-dosis-de-refuerzo-4-meses-PS-y-mayores-de-60.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-12/memo-dosis-de-refuerzo-4-meses-PS-y-mayores-de-60.pdf)\nMemor\u00e1ndum: Recomendaci\u00f3n de intervalo para la aplicaci\u00f3n de la dosis de refuerzo de vacunas contra COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2021-12/memo%20Recomendacion%20de%20intervalo%20para%20aplicacion%20de%20la%20dosis%20de%20refuerzo%20Vacunas%20contra%20COVID-19.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-12/memo%20Recomendacion%20de%20intervalo%20para%20aplicacion%20de%20la%20dosis%20de%20refuerzo%20Vacunas%20contra%20COVID-19.pdf)\nINVESTIGACI\u00d3N REALIZADA POR PROFESIONALES DE LA UNIDAD DE TERAPIA INTENSIVA DE LA CL\u00cdNICA COL\u00d3N DE MAR DEL PLATA:\nPulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach\n[https://www.mdpi.com/2077-0383/10/23/5599/htm](https://www.mdpi.com/2077-0383/10/23/5599/htm)\nSEXTO CONGRESO COLOMBIANO DE ATENCI\u00d3N FARMAC\u00c9UTICA: \u201cIDENTIFICANDO Y PROYECTANDO EL PAPEL DE LA ATENCI\u00d3N FARMAC\u00c9UTICA EN EL CONTEXTO DE LA POSPANDEMIA COVID-19\n[https://revistas.udea.edu.co/index.php/vitae/article/view/348083/20806693](https://revistas.udea.edu.co/index.php/vitae/article/view/348083/20806693)\nRECOMENDACIONES HIGI\u00c9NICO AMBIENTALES PARA LA FABRICACI\u00d3N DE PRODUCTOS M\u00c9DICOS EN EL CONTEXTO DE LA RECONVERSI\u00d3N DE INDUSTRIAS GENERADA POR LA PANDEMIA COVID-19\n[https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-003_Recomendaciones-higienico-ambientales-para-la-fabricacion-de-productos-medicos.v001.pdf](https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-003_Recomendaciones-higienico-ambientales-para-la-fabricacion-de-productos-medicos.v001.pdf)\nInforme especial de vigilancia de seguridad en vacunas en ni\u00f1os, ni\u00f1as y adolescentes\n[https://bancos.salud.gob.ar/sites/default/files/2021-11/Informe_especial_de_vigilancia_de_seguridad_en_vacunas_en_ninios_ninas_adolescentes.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-11/Informe_especial_de_vigilancia_de_seguridad_en_vacunas_en_ninios_ninas_adolescentes.pdf)\nGu\u00eda Cl\u00ednica Para La Atenci\u00f3n Al Paciente Long Covid/Covid Persistente\n[https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_version_final.pdf](https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_version_final.pdf)\nLineamientos t\u00e9cnicos: Dosis adicional al esquema primario y dosis de refuerzo (booster)\n[https://bancos.salud.gob.ar/sites/default/files/2021-11/lineamientos-tecnicos-COVID-19-booster.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-11/lineamientos-tecnicos-COVID-19-booster.pdf)\nVacunas contra la COVID-19. Bolet\u00edn de errores de medicaci\u00f3n de Catalu\u00f1a\n[https://scientiasalut.gencat.cat/bitstream/handle/11351/6420/butll_prev_errors_medicacio_catalunya_2021_19_01_cas.pdf?sequence=2&isAllowed=y](https://scientiasalut.gencat.cat/bitstream/handle/11351/6420/butll_prev_errors_medicacio_catalunya_2021_19_01_cas.pdf?sequence=2&isAllowed=y)\nRECOMENDACIONES PARA EL MANTENIMIENTO DE LAS BPF EN CONTEXTO DE COVID-19\n[https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-004_Recomendaciones-para-el-mantenimiento-de-las.BPF_.v001.pdf|](https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-004_Recomendaciones-para-el-mantenimiento-de-las.BPF_.v001.pdf)\nBloqueantes de receptores de angiotensina-II de novo para el tratamiento de pacientes con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n10-bloqueantes-receptores.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n10-bloqueantes-receptores.pdf)\nLineamientos T\u00e9cnicos: Resumen de recomendaciones vigentes para la Campa\u00f1a Nacional de Vacunaci\u00f3n contra la COVID-19 | 7 de octubre de 2021\n[https://bancos.salud.gob.ar/sites/default/files/2021-10/LT%20COVID-19%20unificado%20Octubre.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-10/LT%20COVID-19%20unificado%20Octubre.pdf)\nCaracter\u00edsticas de las vacunas contra la COVID-19 disponibles en Argentina\n[https://bancos.salud.gob.ar/sites/default/files/2021-10/caracteristicas-de-las-vacunas-contra-la-COVID19-disponibles-en-argentina.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-10/caracteristicas-de-las-vacunas-contra-la-COVID19-disponibles-en-argentina.pdf)\nVaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y riesgo de s\u00edndrome de Guillain-Barr\u00e9\n[https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/vaxzevria-y-riesgo-de-sindrome-de-guillain-barre/](https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/vaxzevria-y-riesgo-de-sindrome-de-guillain-barre/)\nSeroneutralizaci\u00f3n de variantes SARS-CoV-2 Gamma (P.1, Manaos), Alpha (B.1.1.7, Reino Unido) y Lambda (C.37, Andina) en individuos vacunados con Sputnik V e individuos recuperados de la infecci\u00f3n por SARS-CoV-2\n[http://pais.qb.fcen.uba.ar/files/reportes/informe_seroneutralizacion_C37_P1.pdf](http://pais.qb.fcen.uba.ar/files/reportes/informe_seroneutralizacion_C37_P1.pdf)\nEVALUACI\u00d3N DEL POTENCIAL NEUTRALIZANTE DE LOS ANTICUERPOS NATURALES Y LOS GENERADOS POR LAS VACUNAS ASTRAZENECA, SINOPHARM Y SPUTNIK V FRENTE A LA VARIANTE DE PREOCUPACI\u00d3N DELTA EN C\u00d3RDOBA\n[https://www.cba.gov.ar/wp-content/uploads/2021/09/Informe-Delta-en-Co%CC%81rdoba-y-anticuerpos-neutralizantes-en-la-poblacio%CC%81n.pdf?csrt=6863230237421239545](https://www.cba.gov.ar/wp-content/uploads/2021/09/Informe-Delta-en-Co%CC%81rdoba-y-anticuerpos-neutralizantes-en-la-poblacio%CC%81n.pdf?csrt=6863230237421239545)\nRecomendaciones para el diagn\u00f3stico y tratamiento del S\u00edndrome de Trombosis con Trombocitopenia tras la vacunaci\u00f3n frente a COVID-19\n[http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/09/Bolet%C3%ADn-CIME-TTS-sept-2021-v.final_.pdf](http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/09/Bolet%C3%ADn-CIME-TTS-sept-2021-v.final_.pdf)\nTromboprofilaxis farmacol\u00f3gica frente a no trombofilaxis para el tratamiento de pacientes hospitalizados con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n8-tromboprofilaxis.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n8-tromboprofilaxis.pdf)\nManual del Vacunador. Vacuna Comirnaty de Pfizer-BioNTech\n[https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-pfizer.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-pfizer.pdf)\nCOVID-19 Vaccine Media Hub\n[https://covidvaccinehub.org/](https://covidvaccinehub.org/)\nOngoing Living Update of Potential COVID-19 Therapeutics Options: Summary of Evidence. Rapid Review\n[https://iris.paho.org/handle/10665.2/52719](https://iris.paho.org/handle/10665.2/52719)\nManual del Vacunador. Vacuna CONVIDECIA\n[https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-vacuna-convidecia-2021-septiembre.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-vacuna-convidecia-2021-septiembre.pdf)\nAzitromicina para el tratamiento de pacientes con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n9-azitromicina.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n9-azitromicina.pdf)\nTracking the vaccine race: A look at the vaccines in development to fight COVID-19.\n[https://graphics.reuters.com/HEALTH-CORONAVIRUS/VACCINE-TRACKER/xegpbqnlovq/](https://graphics.reuters.com/HEALTH-CORONAVIRUS/VACCINE-TRACKER/xegpbqnlovq/)\nIbuprofeno inhalado para el tratamiento de pacientes con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n12-ibuprofeno-inhalado.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n12-ibuprofeno-inhalado.pdf)\nRECOMENDACI\u00d3N SOBRE ESQUEMAS HETER\u00d3LOGOS DE VACUNACI\u00d3N COVID-19\n[https://bancos.salud.gob.ar/sites/default/files/2021-08/recomendacion-sobre-esquemas-heterologos-de-vacunacion-contra-COVID19.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-08/recomendacion-sobre-esquemas-heterologos-de-vacunacion-contra-COVID19.pdf)\nManual del Vacunador. Vacuna Moderna \u2013 28 de julio de 2021\n[https://bancos.salud.gob.ar/sites/default/files/2021-07/Manual%20vacunador%20MODERNA.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-07/Manual%20vacunador%20MODERNA.pdf)\nSpikevax1(vacuna de ARNm contra la COVID-19 [nucle\u00f3sidos modificados])\n[https://www.ema.europa.eu/en/documents/overview/spikevax-previously-covid-19-vaccine-moderna-epar-medicine-overview_es.pdf](https://www.ema.europa.eu/en/documents/overview/spikevax-previously-covid-19-vaccine-moderna-epar-medicine-overview_es.pdf)\nRecomendaciones para el Abordaje Terap\u00e9utico de Covid-19 en Ni\u00f1os, Ni\u00f1as y Adolescentes\n[https://bancos.salud.gob.ar/sites/default/files/2021-07/abordaje-nnya-covid_0.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-07/abordaje-nnya-covid_0.pdf)\nFarmacovigilancia de vacunas para COVID-19\n[https://covid-19pharmacovigilance.paho.org/index.php](https://covid-19pharmacovigilance.paho.org/index.php)\nClinical trials: COVID-19\n[https://www.recoverytrial.net/results](https://www.recoverytrial.net/results)\nCOVID-19 PREVENCI\u00d3N DE TRANSMISI\u00d3N POR AEROSOLES RECOMENDACIONES\n[https://www.argentina.gob.ar/sites/default/files/covid-19-prevencion-de-transmision-por-aerosoles-2021_0.pdf](https://www.argentina.gob.ar/sites/default/files/covid-19-prevencion-de-transmision-por-aerosoles-2021_0.pdf)\nGu\u00eda provisional de la ISTH para el diagn\u00f3stico y el tratamiento de la trombocitopenia tromb\u00f3tica inmune inducida por vacunas (TTIIV) (actualizada el 20 de Abril de 2021)\n[https://cdn.ymaws.com/www.isth.org/resource/resmgr/ISTH_VITT_Spanish_Guidance_F.pdf](https://cdn.ymaws.com/www.isth.org/resource/resmgr/ISTH_VITT_Spanish_Guidance_F.pdf)\nEmpleo de la vacuna Sputnik V en Argentina: Evaluaci\u00f3n de respuesta humoral frente a la vacunaci\u00f3n. Informe Final Enero\u2010Marzo 2021\n[https://www.conicet.gov.ar/wp-content/uploads/Informe-Sputnik_Buenos-Aires-13.04.2021..pdf](https://www.conicet.gov.ar/wp-content/uploads/Informe-Sputnik_Buenos-Aires-13.04.2021..pdf)\nIvermectina para el tratamiento de pacientes con COVID-19 y expuestos al SARS-CoV-2\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n14-ivermectina.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n14-ivermectina.pdf)\nEsteroides sist\u00e9micos para el tratamiento de pacientes con COVID-19\n[https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n3-esteroides.pdf](https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n3-esteroides.pdf)\nVacuna frente al COVID-19\n[https://seq.es/wp-content/uploads/2021/04/vacunas-covid-4.5.pdf](https://seq.es/wp-content/uploads/2021/04/vacunas-covid-4.5.pdf)\nFicha t\u00e9cnica de VITAMINA D (RACIM)\n[http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/RACIM-Vitamina-D-versi%C3%B3n-2-18.11.2020.pdf](http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/RACIM-Vitamina-D-versi%C3%B3n-2-18.11.2020.pdf)\nFicha t\u00e9cnica de VITAMINA C (RACIM)\n[http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/09/RACIM-Vit-C-versi%C3%B3n-1-01.07.2020-1.pdf](http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/09/RACIM-Vit-C-versi%C3%B3n-1-01.07.2020-1.pdf)\nSuplementos vitam\u00ednicos (Vit. C, D) y Zinc en infecci\u00f3n por COVID-19\n[https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-788-Suplementos-vitami%CC%81nicos-y-Zinc-en-COVID-1.pdf](https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-788-Suplementos-vitami%CC%81nicos-y-Zinc-en-COVID-1.pdf)\nIvermectina para COVID-19\n[https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-823-VA.pdf](https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-823-VA.pdf)\nRACIM de ivermectina (actualizaci\u00f3n de la versi\u00f3n 3)\n[https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/racim-ivermectina-en-covid19-actualizacion-48807](https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/racim-ivermectina-en-covid19-actualizacion-48807)\nActualizaci\u00f3n del manual del vacunador de Sputnik V\n[https://bancos.salud.gob.ar/sites/default/files/2021-02/actualizacion-manual-vacunador-sputnik-v-10-02-21.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-02/actualizacion-manual-vacunador-sputnik-v-10-02-21.pdf)\nManual vacunador Sinopharm\n[https://bancos.salud.gob.ar/sites/default/files/2021-03/manual-vacunador-sinopharm_12-3-2021.pdf](https://bancos.salud.gob.ar/sites/default/files/2021-03/manual-vacunador-sinopharm_12-3-2021.pdf)\nEvaluaci\u00f3n del riesgo por contagio de coronavirus SARS-CoV-2 y medidas preventivas recomendadas en la prestaci\u00f3n de servicios profesionales farmac\u00e9uticos asistenciales (SPFA)\n[https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf](https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf)\nVentilaci\u00f3n y COVID-19 en la Industria\n[https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf](https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf)\nCOVID-19: Acciones regulatorias de ANMAT\n[https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat](https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat)\nPROTOCOLO DE ACTUACI\u00d3N DESDE LAS FARMACIAS COMUNITARIAS\n[https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf](https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf)\nImpacto de los sistemas de ventilaci\u00f3n en la transmisi\u00f3n del SARS\u2013CoV\u20132. Recomendaciones generales para los edificios de uso p\u00fablico\n[https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf](https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf)\nDraft landscape of COVID-19 candidate vaccines\n[https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines](https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines)\nCOVID-19INTERACCIONES MEDICAMENTOSAS\n[https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf](https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf)\nArt\u00edculos cient\u00edficos\nM\u00faltiples reacciones adversas graves a f\u00e1rmacos en un paciente luego de la infecci\u00f3n por COVID-19. Informe de un caso\n[https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/260/134](https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/260/134)\nAllergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057)\nAssociation of Symptoms After COVID-19 Vaccination With Anti\u2013SARS-CoV-2 Antibody Response in the Framingham Heart Study\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552)\nDuration of immunity following full vaccination against SARS-CoV-2: a systematic review\n[https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf](https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf)\nComparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf)\nAntiviral Activity of Echinacea Extract Appears to Include SARS-CoV-2\n[https://www.herbalgram.org/media/17794/032223.pdf](https://www.herbalgram.org/media/17794/032223.pdf)\nSARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated na\u00efve and convalescent lactating participants\n[https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf](https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf)\nEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true)\nEstimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England\n[https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf](https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf)\nUnadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses\n[https://www.science.org/doi/epdf/10.1126/science.abo2523](https://www.science.org/doi/epdf/10.1126/science.abo2523)\nA multinational Delphi consensus to end the COVID-19 public health threat\n[https://www.nature.com/articles/s41586-022-05398-2.pdf](https://www.nature.com/articles/s41586-022-05398-2.pdf)\nGout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study\n[https://onlinelibrary.wiley.com/doi/10.1002/art.42339](https://onlinelibrary.wiley.com/doi/10.1002/art.42339)\nS\u00edndrome de Gianotti-Crosti de localizaci\u00f3n at\u00edpica en un adulto despu\u00e9s de la vacunaci\u00f3n contra el SARS-CoV-2\n[https://www.actasdermo.org/es-pdf-S0001731023000443](https://www.actasdermo.org/es-pdf-S0001731023000443)\nSARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia\n[https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf](https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf)\nOmicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies\n[https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf](https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf)\nStevens-Johnson syndrome related with Comirnaty\u00ae coronavirus disease 2019 vaccine\n[https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf](https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf)\nProtective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants\n[https://www.nejm.org/doi/10.1056/NEJMc2209306](https://www.nejm.org/doi/10.1056/NEJMc2209306)\nEffect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial\n[https://jamanetwork.com/journals/jama/fullarticle/2797483](https://jamanetwork.com/journals/jama/fullarticle/2797483)\nUTILIZACI\u00d3N PRECOZ DE TOCILIZUMAB EN PACIENTES INTERNADOS CON COVID-19 GRAVE Y CR\u00cdTICA: UN ESTUDIO MULTIC\u00c9NTRICO EN LA PROVINCIA DE BUENOS AIRES\n[https://www.medicinabuenosaires.com/revistas/vol83-23/original_7941.pdf](https://www.medicinabuenosaires.com/revistas/vol83-23/original_7941.pdf)\nNeutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2212117?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2212117?articleTools=true)\nShoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf)\nAngiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial\n[https://www.bmj.com/content/bmj/379/bmj-2022-072175.full.pdf](https://www.bmj.com/content/bmj/379/bmj-2022-072175.full.pdf)\nHypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination\n[https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.122.19694](https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.122.19694)\nMechanisms of COVID-19 pathogenesis in diabetes\n[https://journals.physiology.org/doi/epdf/10.1152/ajpheart.00204.2022](https://journals.physiology.org/doi/epdf/10.1152/ajpheart.00204.2022)\nEfficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss\nA Randomized Clinical Trial\n[https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2799843](https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2799843)\nEfficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2214302?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2214302?articleTools=true)\nComparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639791/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639791/pdf/main.pdf)\nPrimary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank\n[https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276781&type=printable](https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276781&type=printable)\nOral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118542?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118542?articleTools=true)\nEfficacy of olive leaves extract on the outcomes of hospitalized covid-19 patients: A randomized, triple-blinded clinical trial\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617633/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617633/pdf/main.pdf)\nExamination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799939](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799939)\nGout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study\n[https://onlinelibrary.wiley.com/doi/10.1002/art.42339](https://onlinelibrary.wiley.com/doi/10.1002/art.42339)\nCovid-19 Vaccine Protection among Children and Adolescents in Qatar\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210058?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210058?articleTools=true)\nTherapeutic advances in COVID-19\n[https://www.nature.com/articles/s41581-022-00642-4.pdf](https://www.nature.com/articles/s41581-022-00642-4.pdf)\nComparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US\n[https://www.bmj.com/content/bmj/379/bmj-2022-071594.full.pdf](https://www.bmj.com/content/bmj/379/bmj-2022-071594.full.pdf)\nSix-Month Follow-up after a Fourth BNT162b2 Vaccine Dose\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2211283?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2211283?articleTools=true)\nHumoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549602/pdf/fimmu-13-992370.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549602/pdf/fimmu-13-992370.pdf)\nSARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated na\u00efve and convalescent lactating participants\n[https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf](https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf)\nEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true)\nEstimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England\n[https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf](https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf)\nUnadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses\n[https://www.science.org/doi/epdf/10.1126/science.abo2523](https://www.science.org/doi/epdf/10.1126/science.abo2523)\nA multinational Delphi consensus to end the COVID-19 public health threat\n[https://www.nature.com/articles/s41586-022-05398-2.pdf](https://www.nature.com/articles/s41586-022-05398-2.pdf)\nETF statement on the loss of activity of anti-spike protein monoclonal antibodies due to emerging SARS-CoV-2 variants of concern\n[https://www.ema.europa.eu/en/documents/public-statement/etf-statement-loss-activity-anti-spike-protein-monoclonal-antibodies-due-emerging-sars-cov-2_en.pdf](https://www.ema.europa.eu/en/documents/public-statement/etf-statement-loss-activity-anti-spike-protein-monoclonal-antibodies-due-emerging-sars-cov-2_en.pdf)\nAllergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057)\nAssociation of Symptoms After COVID-19 Vaccination With Anti\u2013SARS-CoV-2 Antibody Response in the Framingham Heart Study\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552)\nDuration of immunity following full vaccination against SARS-CoV-2: a systematic review\n[https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf](https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf)\nComparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf)\nAntiviral Activity of Echinacea Extract Appears to Include SARS-CoV-2\n[https://www.herbalgram.org/media/17794/032223.pdf](https://www.herbalgram.org/media/17794/032223.pdf)\nCOVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis\n[https://www.frontiersin.org/articles/10.3389/fmed.2022.1023507/pdf](https://www.frontiersin.org/articles/10.3389/fmed.2022.1023507/pdf)\nSARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia\n[https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf](https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf)\nOmicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies\n[https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf](https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf)\nStevens-Johnson syndrome related with Comirnaty\u00ae coronavirus disease 2019 vaccine\n[https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf](https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf)\nProtective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants\n[https://www.nejm.org/doi/10.1056/NEJMc2209306](https://www.nejm.org/doi/10.1056/NEJMc2209306)\nEffect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial\n[https://jamanetwork.com/journals/jama/fullarticle/2797483](https://jamanetwork.com/journals/jama/fullarticle/2797483)\nSARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia\n[https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf](https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf)\nOmicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies\n[https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf](https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf)\nStevens-Johnson syndrome related with Comirnaty\u00ae coronavirus disease 2019 vaccine\n[https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf](https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf)\nProtective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants\n[https://www.nejm.org/doi/10.1056/NEJMc2209306](https://www.nejm.org/doi/10.1056/NEJMc2209306)\nEffect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial\n[https://jamanetwork.com/journals/jama/fullarticle/2797483](https://jamanetwork.com/journals/jama/fullarticle/2797483)\nAllergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057)\nEffectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality\nin children in Argentina, during predominance of delta and omicron covid-19 variants: test\nnegative, case-control study\n[https://www.bmj.com/content/bmj/379/bmj-2022-073070.full.pdf ](https://www.bmj.com/content/bmj/379/bmj-2022-073070.full.pdf)\nAportes de la biotecnolog\u00eda en el diagn\u00f3stico de COVID-19\n[https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/204/105](https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/204/105)\nAdverse drug reactions reported following use of oral COVID-19 therapeutics in New Zealand\nhttps://www.medsafe.govt.nz/profs/PUArticles/December2022/Adverse-drug-reactions-reported-\noral-COVID-19-therapeutics.html\nAssociation of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US\nEssential and Frontline Workers\n[https://jamanetwork.com/journals/jama/fullarticle/2797418?utm_source=substack&utm_mediu](https://jamanetwork.com/journals/jama/fullarticle/2797418?utm_source=substack&utm_mediu)\nm=email\nWhat next for covid-19 vaccines?\n[https://www.bmj.com/content/379/bmj.o2422?utm_source=substack&utm_medium=email](https://www.bmj.com/content/379/bmj.o2422?utm_source=substack&utm_medium=email)\nEnfermedades dermatol\u00f3gicas inmunomediadas desencadenadas por la infecci\u00f3n por SARS-CoV-2\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500085/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500085/pdf/main.pdf)\nTolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial\n[https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(22)00480-7.pdf](https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(22)00480-7.pdf)\nSerious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/pdf/main.pdf)\nEvaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true)\nCOVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study\n[https://cancer.jmir.org/2022/4/e35310/PDF](https://cancer.jmir.org/2022/4/e35310/PDF)\nAn\u00e1lisis de las reacciones adversas a la vacuna contra COVID-19 en la poblaci\u00f3n de la Zona B\u00e1sica de Salud de Cantalejo\n[https://mgyf.org/wp-content/uploads/2022/11/MGYF2022_046-1.pdf](https://mgyf.org/wp-content/uploads/2022/11/MGYF2022_046-1.pdf)\nEstimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796667?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092622](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796667?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092622)\nAssociation of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine\u2013Induced Immunity in Older Adults\n[https://academic.oup.com/cid/article-pdf/75/Supplement_1/S61/45407502/ciac397.pdf](https://academic.oup.com/cid/article-pdf/75/Supplement_1/S61/45407502/ciac397.pdf)\nAssociation Between Vaccination Status and Mortality Among Intubated Patients With COVID-19\u2013Related Acute Respiratory Distress Syndrome\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797179](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797179)\nEffectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575390/pdf/aim-olf-M221856.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575390/pdf/aim-olf-M221856.pdf)\nAssociation between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data\n[https://bmjmedicine.bmj.com/content/bmjmed/1/1/e000297.full.pdf](https://bmjmedicine.bmj.com/content/bmjmed/1/1/e000297.full.pdf)\nMulti-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) in Children and Adolescents\n[https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmrj.12890](https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmrj.12890)\nImpact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review\n[https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900354-6](https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900354-6)\nReaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens\n[https://www.frontiersin.org/articles/10.3389/fimmu.2022.1003094/pdf](https://www.frontiersin.org/articles/10.3389/fimmu.2022.1003094/pdf)\nBiosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals\n[https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010799&type=printable](https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010799&type=printable)\nVaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true)\nAssociation of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies\n[https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790805](https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790805)\nHypersensitivity Reactions to COVID-19 Vaccines\u2014Identify High-risk Children and Vaccinate the Rest\n[https://jamanetwork.com/journals/jamapediatrics/fullarticle/2789414](https://jamanetwork.com/journals/jamapediatrics/fullarticle/2789414)\nDurability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection\n[https://jamanetwork.com/journals/jama/fullarticle/2788986](https://jamanetwork.com/journals/jama/fullarticle/2788986)\nEffects of Vaccination and Previous Infection on Omicron Infections in Children\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2209371?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2209371?articleTools=true)\nAnalysis of Vaccine Reactions After COVID-19 Vaccine Booster Doses Among Pregnant and Lactating Individuals\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795998](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795998)\nEfficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360656/pdf/10549_2022_Article_6693.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360656/pdf/10549_2022_Article_6693.pdf)\nDe las publicaciones a la pr\u00e1ctica cotidiana: tocilizumab en pacientes con COVID-19 grave\n[https://www.medicinabuenosaires.com/revistas/vol82-22/n5/659.pdf](https://www.medicinabuenosaires.com/revistas/vol82-22/n5/659.pdf)\nAssociation of Male Hypogonadism With Risk of Hospitalization for COVID-19\n[https://pubmed.ncbi.nlm.nih.gov/36053534/](https://pubmed.ncbi.nlm.nih.gov/36053534/)\nSeverity of COVID-19 among solid organ transplant recipients in Canada, 2020\u20132021: a prospective, multicentre cohort study\n[https://www.cmaj.ca/content/cmaj/194/33/E1155.full.pdf](https://www.cmaj.ca/content/cmaj/194/33/E1155.full.pdf)\nEffect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004\u201320: a national surveillance study\n[https://www.thelancet.com/action/showPdf?pii=S2666-5247%2822%2900127-6](https://www.thelancet.com/action/showPdf?pii=S2666-5247%2822%2900127-6)\nEffect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)\n[https://www.bmj.com/content/bmj/378/bmj-2022-071230.full.pdf](https://www.bmj.com/content/bmj/378/bmj-2022-071230.full.pdf)\nAssessment of Delayed Large Local Reactions After the First Dose of the SARS-CoV-2 mRNA-1273 Vaccine in Japan\n[https://jamanetwork.com/journals/jamadermatology/fullarticle/2792873](https://jamanetwork.com/journals/jamadermatology/fullarticle/2792873)\nRisk of Appendicitis After mRNA COVID-19 Vaccination in a Danish Population\n[https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2791667](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2791667)\nEvaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy\n[https://www.nejm.org/doi/10.1056/NEJMc2205276](https://www.nejm.org/doi/10.1056/NEJMc2205276)\nS\u00edndrome de Guillain-Barr\u00e9 y trombocitopenia tras la vacunaci\u00f3n contra el SARS-CoV-2 con Moderna. Descripci\u00f3n de un caso\n[https://neurologia.com/articulo/2022138](https://neurologia.com/articulo/2022138)\nProtection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study\n[https://www.medrxiv.org/content/10.1101/2022.09.25.22280341v2](https://www.medrxiv.org/content/10.1101/2022.09.25.22280341v2)\nPatients with previous presumed immediate hypersensitivity reactions to polyethylene glycol (PEG) can safely receive the Pfizer BioNTech BNT162b2 COVID-19 vaccine\n[https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.15821?utm_source=substack&utm_medium=email](https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.15821?utm_source=substack&utm_medium=email)\nFolic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case\u2013control analysis from the UK Biobank\n[https://bmjopen.bmj.com/content/bmjopen/12/8/e062945.full.pdf](https://bmjopen.bmj.com/content/bmjopen/12/8/e062945.full.pdf)\nMyocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439627/pdf/cir-146-802.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439627/pdf/cir-146-802.pdf)\nPrevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial\n[https://www.bmj.com/content/bmj/378/bmj-2022-071245.full.pdf](https://www.bmj.com/content/bmj/378/bmj-2022-071245.full.pdf)\nCan vitamin D protect against covid-19?\n[https://www.bmj.com/content/bmj/378/bmj.o1822.full.pdf](https://www.bmj.com/content/bmj/378/bmj.o1822.full.pdf)\nHumoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain\n[https://www.nature.com/articles/s41598-022-19537-2.pdf](https://www.nature.com/articles/s41598-022-19537-2.pdf)\nMultiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes\n[https://www.cell.com/action/showPdf?pii=S2666-3791%2822%2900271-3](https://www.cell.com/action/showPdf?pii=S2666-3791%2822%2900271-3)\nRisk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex\n[https://www.ahajournals.org/doi/epdf/10.1161/CIRCULATIONAHA.122.059970](https://www.ahajournals.org/doi/epdf/10.1161/CIRCULATIONAHA.122.059970)\nAssociation of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure\n[https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2822%2900536-X](https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2822%2900536-X)\nCOVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology\n[https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2356](https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2356)\nRisk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study\n[https://www.bmj.com/content/bmj/378/bmj-2022-071416.full.pdf](https://www.bmj.com/content/bmj/378/bmj-2022-071416.full.pdf)\nCovid-19: Severe complications during pregnancy are more common in unvaccinated women, study finds\n[https://www.bmj.com/content/bmj/376/bmj.o117.full.pdf](https://www.bmj.com/content/bmj/376/bmj.o117.full.pdf)\nFactores asociados a la anosmia y ageusia en pacientes COVID-19de una provincia peruana\n[https://revistas.udea.edu.co/index.php/iatreia/article/view/346608/20807098](https://revistas.udea.edu.co/index.php/iatreia/article/view/346608/20807098)\nSARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated na\u00efve and convalescent lactating participants\n[https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf](https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf)\nFrom publications to every day clinical practice: tocilizumab in patients with severe covid-19\n[https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7760.pdf](https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7760.pdf)\nAssociation Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers\n[https://jamanetwork.com/journals/jama/fullarticle/2794072](https://jamanetwork.com/journals/jama/fullarticle/2794072)\nOlfactory dysfunction but not COVID-19 severity predicts severity of cognitive sequelae following SARS-CoV-2 infection in Amerindian older adults\n[https://alz.confex.com/alz/2022/meetingapp.cgi/Paper/66868](https://alz.confex.com/alz/2022/meetingapp.cgi/Paper/66868)\nRandomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201662?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201662?articleTools=true)\nAssociation of Homologous and Heterologous Vaccine Boosters With SARS-CoV-2 Infection in BBIBP-CorV Vaccinated Healthcare Personnel\n[https://www.cureus.com/articles/103631-association-of-homologous-and-heterologous-vaccine-boosters-with-sars-cov-2-infection-in-bbibp-corv-vaccinated-healthcare-personnel](https://www.cureus.com/articles/103631-association-of-homologous-and-heterologous-vaccine-boosters-with-sars-cov-2-infection-in-bbibp-corv-vaccinated-healthcare-personnel)\nPirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals\n[https://link.springer.com/content/pdf/10.1007/s10787-022-01027-6.pdf](https://link.springer.com/content/pdf/10.1007/s10787-022-01027-6.pdf)\nRespuesta humoral inducida por la vacuna BBIBP-CorV/Sinopharm COVID-19 en trabajadores de primera l\u00ednea\n[http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/494/681](http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/494/681)\nA Bivalent Omicron-Containing Booster Vaccine against Covid-19\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2208343?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2208343?articleTools=true)\nCovid-19 vaccine does not affect sustained implantation rates after single euploid embryo transfer, a retrospective study with 4868 cases\n[https://academic.oup.com/humrep/article/37/Supplement_1/deac105.038/6619730](https://academic.oup.com/humrep/article/37/Supplement_1/deac105.038/6619730)\nPlacental pathology in women vaccinated and unvaccinated against SARS-CoV-2\n[https://www.ajog.org/action/showPdf?pii=S0002-9378%2822%2900515-4](https://www.ajog.org/action/showPdf?pii=S0002-9378%2822%2900515-4)\nA Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine\n[https://journals.asm.org/doi/epdf/10.1128/mbio.01822-22](https://journals.asm.org/doi/epdf/10.1128/mbio.01822-22)\nWaning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records\n[https://www.bmj.com/content/bmj/378/bmj-2022-071249.full.pdf](https://www.bmj.com/content/bmj/378/bmj-2022-071249.full.pdf)\nEffectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257064/pdf/bmj-2022-071502.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257064/pdf/bmj-2022-071502.pdf)\nCOVID-19 VACCINE COMPARISON CHART from The Medical Letter\n[https://secure.medicalletter.org/downloads/1621g_table.pdf](https://secure.medicalletter.org/downloads/1621g_table.pdf)\nCovid-19 Vaccines \u2014 Immunity, Variants, Boosters\n[https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true)\nVaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true)\nReactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794318](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794318)\nAntiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis\n[https://www.cmaj.ca/content/cmaj/194/28/E969.full.pdf](https://www.cmaj.ca/content/cmaj/194/28/E969.full.pdf)\nEffectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2203209?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2203209?articleTools=true)\nSocial impact of the clinical trials on COVID-19-related vaccines and other drugs\n[https://www.esteve.org/capitulos/social-impact-of-the-clinical-trials-on-covid-19-related-vaccines-and-other-drugs-2/](https://www.esteve.org/capitulos/social-impact-of-the-clinical-trials-on-covid-19-related-vaccines-and-other-drugs-2/)\nDurability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants\n[https://www.nejm.org/doi/pdf/10.1056/NEJMc2210546?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMc2210546?articleTools=true)\nMyocarditis and pericarditis have been reported with Nuvaxovid (Novavax COVID-19 Vaccine)\n[https://www.medsafe.govt.nz/safety/Alerts/nuvaxovid-myocarditis.asp](https://www.medsafe.govt.nz/safety/Alerts/nuvaxovid-myocarditis.asp)\nBreakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City\n[https://www.thelancet.com/action/showPdf?pii=S2665-9913%2822%2900190-4](https://www.thelancet.com/action/showPdf?pii=S2665-9913%2822%2900190-4)\nPostacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases\n[https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2822%2900450-4](https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2822%2900450-4)\nRelationship between ABO Blood Group Distribution and COVID-19 Infection in Patients Admitted to the ICU: A Multicenter Observational Spanish Study\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181327/pdf/jcm-11-03042.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181327/pdf/jcm-11-03042.pdf)\nInvestigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination\n[https://www.science.org/doi/epdf/10.1126/sciadv.abm7201](https://www.science.org/doi/epdf/10.1126/sciadv.abm7201)\nHeterotypic vaccination responses against SARS-CoV-2 Omicron BA.2\n[https://www.nature.com/articles/s41421-022-00435-w.pdf](https://www.nature.com/articles/s41421-022-00435-w.pdf)\nRespiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination\n[https://www.science.org/doi/epdf/10.1126/sciimmunol.add4853](https://www.science.org/doi/epdf/10.1126/sciimmunol.add4853)\nVenous Thromboembolism Prophylaxis in COVID-19: Making Sense of the Evidence\n[https://www.acpjournals.org/doi/10.7326/M22-1425](https://www.acpjournals.org/doi/10.7326/M22-1425)\nOral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis\n[https://evidence.nejm.org/doi/pdf/10.1056/EVIDoa2200145](https://evidence.nejm.org/doi/pdf/10.1056/EVIDoa2200145)\nOutcomes of SARS-CoV-2 Reinfection\n[https://www.researchsquare.com/article/rs-1749502/v1](https://www.researchsquare.com/article/rs-1749502/v1)\nMultisystem Inflammatory Syndrome Temporally Related to COVID-19 in Children From Latin America and the Caribbean Region: A Systematic Review With a Meta-Analysis of Data From Regional Surveillance Systems\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082071/pdf/fped-10-881765.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082071/pdf/fped-10-881765.pdf)\nA Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response\n[https://journals.lww.com/transplantjournal/Fulltext/2022/07000/A_Fourth_Dose_of_COVID_19_Vaccine_Does_Not_Induce.22.aspx](https://journals.lww.com/transplantjournal/Fulltext/2022/07000/A_Fourth_Dose_of_COVID_19_Vaccine_Does_Not_Induce.22.aspx)\nCovid-19 Vaccines \u2014 Immunity, Variants, Boosters\n[https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true)\nTwo new oral antivirals for covid-19: molnupiravir and nirmatrelvir plus ritonavir\n[https://dtb.bmj.com/content/dtb/60/5/73.full.pdf](https://dtb.bmj.com/content/dtb/60/5/73.full.pdf)\nCaracterizaci\u00f3n de las manifestaciones cut\u00e1neas por infecci\u00f3n de SARS-COV-2 en pacientes de Am\u00e9rica Latina\n[https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001083](https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001083)\nReactivaci\u00f3n del virus varicela z\u00f3ster tras la vacunaci\u00f3n contra la COVID-19\n[https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S021392512200137X](https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S021392512200137X)\nLesiones acroisqu\u00e9micas tras la vacunaci\u00f3n contra la COVID-19\n[https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122000582](https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122000582)\nVasculitis leucocitocl\u00e1stica asociada a la vacuna ARNm contra la COVID-19\n[https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001381](https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001381)\nColchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/pdf/bjgpjul-2022-72-720-butler-fl-oa-p.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/pdf/bjgpjul-2022-72-720-butler-fl-oa-p.pdf)\nEffect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial\n[https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900163-1](https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900163-1)\nMikania glomerata Spreng. (Asteraceae): seu uso terap\u00eautico e seu potencial na Pandemia de COVID-19\n[https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1292/1037](https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1292/1037)\nmRNA-based COVID-19 Vaccines Booster Dose: Benefits, Risks and Coverage\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13103/10836](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13103/10836)\nThe Effect of Diabetes Mellitus on Mortality in Patients Hospitalized Intensive Care Unit in Covid-19 Pandemic\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11880/10858](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11880/10858)\nDifferences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2\n[https://www.journalofinfection.com/action/showPdf?pii=S0163-4453%2822%2900248-1](https://www.journalofinfection.com/action/showPdf?pii=S0163-4453%2822%2900248-1)\nRandomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)\n[https://www.nature.com/articles/s41598-022-13920-9](https://www.nature.com/articles/s41598-022-13920-9)\nSafety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study\n[https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00426-1/fulltext](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00426-1/fulltext)\nReactivaci\u00f3n de glomerulonefritis l\u00fapica en asociaci\u00f3n temporal con vacunas anti sars-cov-2\n[https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/casuistica_7802.pdf](https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/casuistica_7802.pdf)\nAssociations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study\n[https://www.thelancet.com/action/showPdf?pii=S2213-8587%2822%2900158-9](https://www.thelancet.com/action/showPdf?pii=S2213-8587%2822%2900158-9)\nProtection vaccinale et immunit\u00e9 \u00ab naturelle \u00bb face \u00e0 la COVID-19 : \u00e9quivalence ?\n[http://www.minerva-ebm.be/FR/GetPdf/2306?articleId=2262](http://www.minerva-ebm.be/FR/GetPdf/2306?articleId=2262)\nClassification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases\n[https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.19163](https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.19163)\nFrequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia\n[https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full](https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full)\nEffect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial\n[https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900186-2](https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900186-2)\nHeterologous booster response after inactivated virus BBIBP-CorV vaccination in older people\n[https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00427-3.pdf](https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00427-3.pdf)\nImmunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA1273\n[https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00248-8.pdf](https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00248-8.pdf)\nDrug treatments for covid-19: living systematic review and network meta-analysis\n[https://www.bmj.com/content/370/bmj.m2980#:~:text=Conclusions,patients%20with%20severe%20covid%2D19](https://www.bmj.com/content/370/bmj.m2980#:~:text=Conclusions,patients%20with%20severe%20covid%2D19).\nEffectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288143/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288143/pdf/main.pdf)\nAutoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care\n[https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9](https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9)\nAutoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine \u2013 no longer exclusive to mRNA vaccine?\n[https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15350](https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15350)\nVirologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment\n[https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac496/6611663?login=false](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac496/6611663?login=false)\nAssociation of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants\n[https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2793109](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2793109)\nProbiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757475/pdf/KGMI_14_2018899.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757475/pdf/KGMI_14_2018899.pdf)\nAnalysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide\n[https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac446/6603291?login=false](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac446/6603291?login=false)\nApplication of normative documents for determination of biocidal activity of disinfectants and antiseptics dedicated to the medical area: a narrative review\n[https://www.journalofhospitalinfection.com/action/showPdf?pii=S0195-6701%2822%2900108-6](https://www.journalofhospitalinfection.com/action/showPdf?pii=S0195-6701%2822%2900108-6)\nFrequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia\n[https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full](https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full)\nIvermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial\n[https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v1](https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v1)\nLesiones faciales de vit\u00edligo tras la administraci\u00f3n de la vacuna frente a SARS-CoV-2\n[https://www.actasdermo.org/es-pdf-S0001731022001600](https://www.actasdermo.org/es-pdf-S0001731022001600)\nUso de ciclosporina en dermatolog\u00eda durante la pandemia de COVID-19\n[https://www.actasdermo.org/es-pdf-S0001731022004124](https://www.actasdermo.org/es-pdf-S0001731022004124)\nEfficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201300?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201300?articleTools=true)\nRisk factors for SARS-CoV-2 infection and transmission in households with asthmatic and allergic children. A prospective surveillance study\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/)\nTargeting SARS-CoV-2: An overview of COVID-19 treatments\n[https://www.medsafe.govt.nz/profs/PUArticles/June2022/Targeting-SARs-CoV-2-Overview-COVID-19-treatments.html](https://www.medsafe.govt.nz/profs/PUArticles/June2022/Targeting-SARs-CoV-2-Overview-COVID-19-treatments.html)\nAssessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792068](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792068)\nSevere acute hepatitis in children: investigate SARS-CoV-2 superantigens\n[https://www.thelancet.com/action/showPdf?pii=S2468-1253%2822%2900166-2](https://www.thelancet.com/action/showPdf?pii=S2468-1253%2822%2900166-2)\nFamotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm\n[https://molmed.biomedcentral.com/track/pdf/10.1186/s10020-022-00483-8.pdf](https://molmed.biomedcentral.com/track/pdf/10.1186/s10020-022-00483-8.pdf)\nAdvances in respiratory protective equipment: practical experiences of CleanSpace\u00ae HALO\u2122 by healthcare workers\n[https://www.journalofhospitalinfection.com/article/S0195-6701(22)00078-0/fulltext#relatedArticles](https://www.journalofhospitalinfection.com/article/S0195-6701(22)00078-0/fulltext#relatedArticles)\nEffectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis\n[https://www.bmj.com/content/377/bmj-2022-069989](https://www.bmj.com/content/377/bmj-2022-069989)\nProtection and Waning of Natural and Hybrid Immunity to SARS-CoV-2\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118946](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118946)\nEpidemiology of VITT (Vaccine-induced immune thrombotic thrombocytopenia)\n[https://www.sciencedirect.com/science/article/pii/S0037196322000051](https://www.sciencedirect.com/science/article/pii/S0037196322000051)\nCOVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing\n[https://www.mdpi.com/2076-393X/10/4/594](https://www.mdpi.com/2076-393X/10/4/594)\nAddition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial\n[https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11958/10756](https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11958/10756)\nAssociation of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance\n[https://jamanetwork.com/journals/jama/fullarticle/2792524](https://jamanetwork.com/journals/jama/fullarticle/2792524)\nMortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study\n[https://academic.oup.com/fampra/advance-article/doi/10.1093/fampra/cmac041/6585930?login=false](https://academic.oup.com/fampra/advance-article/doi/10.1093/fampra/cmac041/6585930?login=false)\nAntibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study\n[https://journals.plos.org/plosmedicine/article/authors?id=10.1371/journal.pmed.1003991](https://journals.plos.org/plosmedicine/article/authors?id=10.1371/journal.pmed.1003991)\nEffect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID-19\n[https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.763](https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.763)\nBNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2205011](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2205011)\nCetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial\n[https://journals.sagepub.com/doi/10.1177/00220345221102310](https://journals.sagepub.com/doi/10.1177/00220345221102310)\nEffectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5\u201311 years in Italy: a retrospective analysis of January\u2013April, 2022\n[https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2901185-0](https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2901185-0)\nImbalance in baseline characteristics in molnupiravir trials\n[https://www.bmj.com/content/377/bmj.o977](https://www.bmj.com/content/377/bmj.o977)\nIncidence of Guillain-Barr\u00e9 Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink\n[https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791533](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791533)\nCentral obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine\n[https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3465](https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3465)\nTwo new oral antivirals for covid-19: molnupiravir and nirmatrelvir plus ritonavir\n[https://dtb.bmj.com/content/dtb/60/5/73.full.pdf](https://dtb.bmj.com/content/dtb/60/5/73.full.pdf)\nEffectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis\n[https://www.bmj.com/content/bmj/377/bmj-2022-069989.full.pdf](https://www.bmj.com/content/bmj/377/bmj-2022-069989.full.pdf)\nEffectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5\u201311 Years and Adolescents Aged 12\u201315 Years \u2014 PROTECT Cohort, July 2021\u2013February 2022\n[https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7111e1-H.pdf](https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7111e1-H.pdf)\nEffect of Early Treatment with Ivermectin among Patients with Covid-19\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true)\nAntibody durability at 1 year after Sputnik V vaccination\n[https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900176-1](https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900176-1)\nDoes smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies\n[https://www.sciencedirect.com/science/article/pii/S0033350621004741?via%3Dihub](https://www.sciencedirect.com/science/article/pii/S0033350621004741?via%3Dihub)\nSARS-CoV-2 vaccine-associated-tinnitus: A review\n[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788157/pdf/main.pdf](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788157/pdf/main.pdf)\nProtection by a Fourth Dose of BNT162b2 against Omicron in Israel\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201570?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201570?articleTools=true)\nSARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies\n[https://www.science.org/doi/epdf/10.1126/scitranslmed.abn8543](https://www.science.org/doi/epdf/10.1126/scitranslmed.abn8543)\nInhibition of Respiratory RNA Viruses by a Composition of Ionophoric Polyphenols with Metal Ions\n[https://www.mdpi.com/1424-8247/15/3/377/htm](https://www.mdpi.com/1424-8247/15/3/377/htm)\nEffect of Early Treatment with Ivermectin among Patients with Covid-19\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true)\nRisks and burdens of incident diabetes in long COVID: a cohort study\n[https://www.sciencedirect.com/science/article/pii/S2213858722000444](https://www.sciencedirect.com/science/article/pii/S2213858722000444)\nPersistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report\n[https://link.springer.com/content/pdf/10.1007/s10875-021-01158-5.pdf](https://link.springer.com/content/pdf/10.1007/s10875-021-01158-5.pdf)\nEfficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities\nThe I-TECH Randomized Clinical Trial\n[https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362](https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362)\nThe presence of serum anti-SARS-CoV-2 IgA appears to protect primary health care workers from COVID-19\n[https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149655](https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149655)\nUse of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir\n[https://www.dovepress.com/getfile.php?fileID=79350](https://www.dovepress.com/getfile.php?fileID=79350)\nCOVID-19-Associated Croup in Children\n[https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-056492/185378/COVID-19-Associated-Croup-in-Children](https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-056492/185378/COVID-19-Associated-Croup-in-Children)\nAutoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care\n[https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9](https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9)\nSARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis\n[https://www.journal-of-hepatology.eu/article/S0168-8278(22)00234-3/pdf](https://www.journal-of-hepatology.eu/article/S0168-8278(22)00234-3/pdf)\nBNT162b2 Protection against the Omicron Variant in Children and Adolescents\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2202826?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2202826?articleTools=true)\nManagement of Drug Interactions With Nirmatrelvir/Ritonavir (Paxlovid\u00ae): Resource for Clinicians\n[https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-paxlovid-drug-interactions-resource-5-6-22-v1.1.pdf](https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-paxlovid-drug-interactions-resource-5-6-22-v1.1.pdf)\nDurability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents\n[https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2021-055505/185412/Durability-of-SARS-CoV-2-Antibodies-From-Natural](https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2021-055505/185412/Durability-of-SARS-CoV-2-Antibodies-From-Natural)\nSafety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2200674?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2200674?articleTools=true)\nProtection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection\n[https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118691?articleTools=true](https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118691?articleTools=true)\nMinisterio de Salud: Recomendaciones\n- Naci\u00f3n:\n[https://www.boletinoficial.gob.ar/busquedaAvanzada/busquedaEspecial](https://www.boletinoficial.gob.ar/busquedaAvanzada/busquedaEspecial)\n- Provincia de Buenos Aires:\n[https://normas.gba.gob.ar/covid-19](https://normas.gba.gob.ar/covid-19)\nOrganizaci\u00f3n Panamericana de la Salud (OPS) \u2013 Argentina / CDC\nActualizaci\u00f3n semanal COVID-19 \u2013 Argentina\n[https://www.paho.org/es/actualizacion-semanal-covid-19-argentina](https://www.paho.org/es/actualizacion-semanal-covid-19-argentina)\nOPS: cursos sobre COVID-19 en espa\u00f1ol\n[https://www.campusvirtualsp.org/es/covid-19](https://www.campusvirtualsp.org/es/covid-19)\nOPS Recursos de informaci\u00f3n relacionados con el nuevo coronavirus\n[https://www.paho.org/arg/index.php?option=com_content&view=article&id=10430:coronavirus&Itemid=226](https://www.paho.org/arg/index.php?option=com_content&view=article&id=10430:coronavirus&Itemid=226)\nVitrina del conocimiento: Nuevo coronavirus\n[https://bvsalud.org/vitrinas/es/post_vitrines/nuevo_coronavirus/](https://bvsalud.org/vitrinas/es/post_vitrines/nuevo_coronavirus/)\nCDC \u2013 Centros para el Control y la Prevenci\u00f3n de Enfermedades \u2013 USA Recomendaciones, c\u00f3mo protegerse\n[https://espanol.cdc.gov/enes/coronavirus/2019-ncov/index.html](https://espanol.cdc.gov/enes/coronavirus/2019-ncov/index.html)\nClasificaciones y definiciones de las variantes del SARS-CoV-2\n[https://espanol.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html](https://espanol.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html)\n.", "language": null, "image": null, "pagetype": null, "links": ["https://www.colfarma.info/colfarma/asuntos-laborales/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/matricula/", "https://www.colfarmaonline.org.ar/", "https://wa.me/5492216547529", "https://www.colfarma.info/colfarma/buscar/", "https://www.colfarma.info/colfarma", "javascript:;", "https://twitter.com/colfarma", "https://www.facebook.com/colfarma", "https://www.instagram.com/colfarma_/", "https://www.youtube.com/@COLFARMAoficial", "https://www.colfarma.info/colfarma/", "https://www.colfarma.info/colfarma/institucional/", "https://www.colfarma.info/colfarma/institucional/quienes-somos/", "https://www.colfarma.info/colfarma/institucional/consejo-directivo/", "https://www.colfarma.info/colfarma/institucional/comisiones-internas/", "https://www.colfarma.info/colfarma/institucional/tribunal-de-disciplina/", "https://www.colfarma.info/colfarma/institucional/filiales/", "https://www.colfarma.info/colfarma/departamentos/", "https://www.colfarma.info/colfarma/mapa-del-sitio/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/matricula/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/sistema-unificado-cat-a/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/mala-praxis/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/residuos-patogenicos/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/multas/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/lista-de-precios/", "https://www.colfarma.info/colfarma/obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/adhesion/", "https://www.colfarma.info/colfarma/obras-sociales/listado-de-os-y-pagos/listado-de-obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/listado-de-os-y-pagos/listado-de-obras-sociales/estado-de-pagos-de-obras-sociales/", "https://www.colfarma.info/colfarma/prensa/boletines-electronicos/boletin-electronico-de-obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/filiales/", "https://www.colfarma.info/colfarma/obras-sociales/centralizados/", "http://www.adminportal.cfpba.org.ar/logonportal/frmlogonportaleswebs.aspx?ReturnUrl=http://www.adminportal.cfpba.org.ar/farmaceuticos/DenunciaDrogueria.aspx", "https://www.colfarma.info/colfarma/relaciones-profesionales/", "https://www.colfarma.info/colfarma/relaciones-profesionales/tramites/", "https://www.colfarma.info/colfarma/relaciones-profesionales/legislacion/", "https://www.colfarma.info/colfarma/relaciones-profesionales/especialides-farmaceuticas/", "https://www.colfarma.info/colfarma/relaciones-profesionales/psicotropicos-y-estupefacientes/", "https://www.colfarma.info/colfarma/cientifica/", "https://www.colfarma.info/colfarma/cientifica/deap/otras-actividades-cientificas-2/", "https://www.colfarma.info/colfarma/cientifica/nanofarmacia/", "https://www.colfarma.info/colfarma/cientifica/laboratorio-ccbppf/", "https://www.colfarma.info/colfarma/cientifica/deap/", "https://www.colfarma.info/colfarma/material_de_consulta_bppf/", "https://www.colfarma.info/colfarma/relaciones-profesionales/oficina-de-denuncias/", "https://www.colfarma.info/colfarma/asuntos-laborales/", "https://www.colfarma.info/colfarma/simuladores-on-line/", "https://www.colfarma.info/colfarma/oportunidades-profesionales/", "https://www.colfarma.info/colfarma/asuntos-laborales/oportunidades-profesionales/venta-de-establecimientos-2/", "https://www.colfarma.info/colfarma/asuntos-laborales/remuneraciones-farmaceuticas/", "https://www.colfarma.info/colfarma/herramientas-para-colegas/", "https://www.colfarma.info/colfarma/comision-provincial-de-asuntos-laborales-cpalpba/", "https://www.colfarma.info/colfarma/observatorio-laboral-farmaceutico/", "https://www.colfarma.info/colfarma/biblioteca/", "https://www.colfarma.info/colfarma/cientifica/rpvf/", "https://www.colfarma.info/colfarma/biblioteca/cimf/", "https://www.colfarma.info/colfarma/material_de_consulta_bppf/", "https://www.colfarma.info/colfarma/biblioteca/catalogo-bibliografico/", "https://www.colfarma.info/colfarma/biblioteca/publicaciones-cientificas-2/", "https://www.colfarma.info/colfarma/biblioteca/4915-2/", "https://www.colfarma.info/colfarma/subsidios/", "https://www.colfarma.info/colfarma/hospital/", "https://www.colfarma.info/colfarma/industria-y-drogueria/", "https://www.colfarma.info/colfarma/deportes/", "https://www.colfarma.info/colfarma/prensa/", "https://www.colfarma.info/colfarma/prensa/boletines-electronicos/", "https://www.colfarma.info/colfarma/prensa/comunicados-de-prensa/", "https://www.colfarma.info/colfarma/prensa/campanas-de-difusion/", "https://www.colfarma.info/colfarma/prensa/boletin-farmaceutico-bonaerense/", "https://www.colfarma.info/colfarma/tad/", "https://www.colfarma.info/colfarma/nuevo-sistema-de-credencial-digital/", "https://www.colfarma.info/colfarma/noticias/", "javascript:;", "https://www.colfarma.info/colfarma/author/agnese-pravisani/", "https://bancos.salud.gob.ar/sites/default/files/2023-06/actualizacion-lt-covid.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-05/memo-actualizacion-refuerzo-covid-19_03-5-2023.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf", "http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2023/05/Actualizacio%C3%ACn-perio%C3%ACdica-ESAVI-vacunas-COVID-19-ABRIL-2023.pdf", "https://www.argentina.gob.ar/coronavirus/vacuna/aplicadas", "https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-sputnik-light.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-02/manual-moderna-bivariante.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-01/refuerzos-vacunacion-contra-COVID-19-en-ni%C3%B1os-ni%C3%B1as-adolescentes.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-01/uso-de-vacuna-contra-COVID-19-formulacion-pediatrica-del-laboratorio-moderna.pdf", "https://bancos.salud.gob.ar/sites/default/files/2023-01/2023-01-manual-pfizer-bivariante.pdf", "https://www.who.int/es/activities/tracking-SARS-CoV-2-variants/tracking-SARS-CoV-2-variants", "https://iris.paho.org/handle/10665.2/56734", "https://www.medicinabuenosaires.com/revistas/vol82-22/n5/641.pdf", "https://www.argentina.gob.ar/noticias/salud-recuerda-la-importancia-de-aplicar-los-refuerzos-de-vacuna-contra-covid-19", "https://bancos.salud.gob.ar/sites/default/files/2022-12/Tercer%20refuerzo%20en%20personas%20de%2018%20a%C3%B1os%20o%20m%C3%A1s.pdf", "https://www.argentina.gob.ar/noticias/frente-la-suba-de-casos-de-covid-19-salud-recomienda-la-poblacion-aplicarse-los-refuerzos", "https://bancos.salud.gob.ar/sites/default/files/2022-12/informe-19-noviembre-2022.pdf", "https://iris.paho.org/bitstream/handle/10665.2/56512/OPSFPLIMCOVID190032_spa.pdf?sequence=1&isAllowed=y", "https://portal-coronavirus.gba.gob.ar/docs/instituciones/Recomendaciones-para-residencias-de-personas-mayores.pdf", "https://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2022/docs/NI_MUH_FV_07_2022-trastonos-menstruales.pdf", "http://www.navarra.es/NR/rdonlyres/6EAA15A8-75D9-4C43-B218-98D590FC247D/483026/FichaEvusheldTRATAMIENTO.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-11/II_informe_impacto_pandemia_sobre_coberturas_vacunacion.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-11/lineamientos-tecnicos-tercer-refuerzo.pdf", "https://iris.paho.org/bitstream/handle/10665.2/56484/v46e1782022.pdf?sequence=1&isAllowed=y", "https://www.univadis.es/viewarticle/posible-impacto-de-la-covid-19-en-el-aumento-de-casos-en-espana-de-enfermedad-neumococica-por-cepas-resistentes-a-antibioticos-771372", "https://www.agenciacyta.org.ar/2022/10/comprueban-que-las-mujeres-vacunadas-contra-el-covid-19-transfieren-proteccion-a-sus-hijos-a-traves-de-la-leche-materna-un-hallazgo-clave-para-los-menores-de-6-meses/", "https://www.andavac.es/campanas/covid/informacion-para-profesionales/preguntas-frecuentes/", "https://iris.paho.org/bitstream/handle/10665.2/56298/COVID-19SitRep80_spa.pdf?sequence=1&isAllowed=y", "https://iris.paho.org/handle/10665.2/56207", "https://www.aepap.org/sites/default/files/noticia/archivos-adjuntos/np_vuelta_al_cole_-_precauciones_virus.pdf", "https://www.fip.org/file/5227", "https://www.aemps.gob.es/medicamentos-de-uso-humano/acceso-a-medicamentos-en-situaciones-especiales/criterios-para-valorar-la-administracion-de-las-nuevas-alternativas-terapeuticas-antivirales-frente-a-la-infeccion-por-sars-cov-2/", "https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7779.pdf", "http://www.nefrologiaargentina.org.ar/numeros/2022/volumen20_1/PremioMiatello.pdf", "http://solp-admin.diper-it.com/api/uploads/magazinearticles/ARGENVAC-sera-una-herramienta-para-convivir-con-el-virus-de-COVID-19/Preview_Revista_SOLP_62_Docena.pdf", "https://www.sap.org.ar/uploads/documentos/documentos_vacunacion-contra-covid-19-en-ninos-y-ninas-de-6-meses-a-3-anos-y-refuerzo-de-3-y-4-anos-de-edad-306.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-07/manual-vacunador-moderna-3-a-5-anos.pdf", "https://www.argentina.gob.ar/salud/conetec/actualizaciones", "https://www.actasdermo.org/es-pdf-S0001731022004689", "https://www.argentina.gob.ar/coronavirus/vacuna/preguntas-frecuentes", "https://www.revistarenal.org.ar/index.php/rndt/article/view/758/1213", "https://www.who.int/es/news/item/11-06-2021-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness", "https://bancos.salud.gob.ar/sites/default/files/2022-05/lineamientos-primer-refuerzo-personas-edad-5-11.pdf", "https://www.evidencia.org/index.php/Evidencia/article/view/6997/4660", "https://bancos.salud.gob.ar/sites/default/files/2022-04/manual-vacunador-moderna-desde-6-anos.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-04/covid-19-lineamientos-tecnicos-segundo-refuerzo.pdf", "https://www.evidencia.org/index.php/Evidencia/article/view/7007/4676", "https://bancos.salud.gob.ar/sites/default/files/2022-03/memorandum_17-03_Vacunas_exterior.pdf", "https://www.argentina.gob.ar/sites/default/files/informe-rapido-covid-19-n15-baricitinib.pdf", "https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/plant-based.html", "https://evidenciasenpediatria.es/files/41-14112-RUTA/5_ACV_Vacuna_COVID.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-03/manual-pfizer-pediatrica.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-02/lineamientos-tecnicos_unificado-covid19-2022.pdf", "https://gacetamedica.com/wp-content/uploads/2021/02/Periodo-de-detecci%C3%B3n-de-SARS-CoV-2-a-trav%C3%A9s-de-PCR-y-Test-de-ant%C3%ADgenos-2.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-01/nuevas-condiciones-aislamiento-covid-19_2022-01-18.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-01/memo-personas-gestantes-11-01-22.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-01/comunicacion-medidas-ce.pdf", "https://bancos.salud.gob.ar/sites/default/files/2022-01/algoritmos-definiciones-covid19-2022.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-12/memo-dosis-de-refuerzo-4-meses-PS-y-mayores-de-60.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-12/memo%20Recomendacion%20de%20intervalo%20para%20aplicacion%20de%20la%20dosis%20de%20refuerzo%20Vacunas%20contra%20COVID-19.pdf", "https://www.mdpi.com/2077-0383/10/23/5599/htm", "https://revistas.udea.edu.co/index.php/vitae/article/view/348083/20806693", "https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-003_Recomendaciones-higienico-ambientales-para-la-fabricacion-de-productos-medicos.v001.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-11/Informe_especial_de_vigilancia_de_seguridad_en_vacunas_en_ninios_ninas_adolescentes.pdf", "https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_version_final.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-11/lineamientos-tecnicos-COVID-19-booster.pdf", "https://scientiasalut.gencat.cat/bitstream/handle/11351/6420/butll_prev_errors_medicacio_catalunya_2021_19_01_cas.pdf?sequence=2&isAllowed=y", "https://safybi.org/wp-content/uploads/2021/01/GO-SAFYBI-004_Recomendaciones-para-el-mantenimiento-de-las.BPF_.v001.pdf", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n10-bloqueantes-receptores.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-10/LT%20COVID-19%20unificado%20Octubre.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-10/caracteristicas-de-las-vacunas-contra-la-COVID19-disponibles-en-argentina.pdf", "https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2021-seguridad-1/vaxzevria-y-riesgo-de-sindrome-de-guillain-barre/", "http://pais.qb.fcen.uba.ar/files/reportes/informe_seroneutralizacion_C37_P1.pdf", "https://www.cba.gov.ar/wp-content/uploads/2021/09/Informe-Delta-en-Co%CC%81rdoba-y-anticuerpos-neutralizantes-en-la-poblacio%CC%81n.pdf?csrt=6863230237421239545", "http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/09/Bolet%C3%ADn-CIME-TTS-sept-2021-v.final_.pdf", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n8-tromboprofilaxis.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-pfizer.pdf", "https://covidvaccinehub.org/", "https://iris.paho.org/handle/10665.2/52719", "https://bancos.salud.gob.ar/sites/default/files/2021-09/manual-vacunador-vacuna-convidecia-2021-septiembre.pdf", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n9-azitromicina.pdf", "https://graphics.reuters.com/HEALTH-CORONAVIRUS/VACCINE-TRACKER/xegpbqnlovq/", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n12-ibuprofeno-inhalado.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-08/recomendacion-sobre-esquemas-heterologos-de-vacunacion-contra-COVID19.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-07/Manual%20vacunador%20MODERNA.pdf", "https://www.ema.europa.eu/en/documents/overview/spikevax-previously-covid-19-vaccine-moderna-epar-medicine-overview_es.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-07/abordaje-nnya-covid_0.pdf", "https://covid-19pharmacovigilance.paho.org/index.php", "https://www.recoverytrial.net/results", "https://www.argentina.gob.ar/sites/default/files/covid-19-prevencion-de-transmision-por-aerosoles-2021_0.pdf", "https://cdn.ymaws.com/www.isth.org/resource/resmgr/ISTH_VITT_Spanish_Guidance_F.pdf", "https://www.conicet.gov.ar/wp-content/uploads/Informe-Sputnik_Buenos-Aires-13.04.2021..pdf", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n14-ivermectina.pdf", "https://www.argentina.gob.ar/sites/default/files/informe-covid-19-n3-esteroides.pdf", "https://seq.es/wp-content/uploads/2021/04/vacunas-covid-4.5.pdf", "http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/12/RACIM-Vitamina-D-versi%C3%B3n-2-18.11.2020.pdf", "http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2020/09/RACIM-Vit-C-versi%C3%B3n-1-01.07.2020-1.pdf", "https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-788-Suplementos-vitami%CC%81nicos-y-Zinc-en-COVID-1.pdf", "https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-823-VA.pdf", "https://www.fundacionfemeba.org.ar/blog/farmacologia-7/post/racim-ivermectina-en-covid19-actualizacion-48807", "https://bancos.salud.gob.ar/sites/default/files/2021-02/actualizacion-manual-vacunador-sputnik-v-10-02-21.pdf", "https://bancos.salud.gob.ar/sites/default/files/2021-03/manual-vacunador-sinopharm_12-3-2021.pdf", "https://www.sefac.org/system/files/2020-06/Documento%20SEFAC%20evaluaci%C3%B3n%20de%20riesgos%20en%20SPFA%20y%20coronavirus_0.pdf", "https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf", "https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat", "https://www.colfacor.org.ar/administrador_web/kcfinder/upload/files/info_coronavirus_farmacias%284%29.pdf", "https://www.comunidad.madrid/sites/default/files/doc/sanidad/samb/doc_tec_ventilacion_el_sars-cov-2.pdf", "https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines", "https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf", "https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/260/134", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552", "https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf", "https://www.herbalgram.org/media/17794/032223.pdf", "https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true", "https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf", "https://www.science.org/doi/epdf/10.1126/science.abo2523", "https://www.nature.com/articles/s41586-022-05398-2.pdf", "https://onlinelibrary.wiley.com/doi/10.1002/art.42339", "https://www.actasdermo.org/es-pdf-S0001731023000443", "https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf", "https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf", "https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf", "https://www.nejm.org/doi/10.1056/NEJMc2209306", "https://jamanetwork.com/journals/jama/fullarticle/2797483", "https://www.medicinabuenosaires.com/revistas/vol83-23/original_7941.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2212117?articleTools=true", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf", "https://www.bmj.com/content/bmj/379/bmj-2022-072175.full.pdf", "https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.122.19694", "https://journals.physiology.org/doi/epdf/10.1152/ajpheart.00204.2022", "https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2799843", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2214302?articleTools=true", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639791/pdf/main.pdf", "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0276781&type=printable", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118542?articleTools=true", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617633/pdf/main.pdf", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799939", "https://onlinelibrary.wiley.com/doi/10.1002/art.42339", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210058?articleTools=true", "https://www.nature.com/articles/s41581-022-00642-4.pdf", "https://www.bmj.com/content/bmj/379/bmj-2022-071594.full.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2211283?articleTools=true", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549602/pdf/fimmu-13-992370.pdf", "https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true", "https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf", "https://www.science.org/doi/epdf/10.1126/science.abo2523", "https://www.nature.com/articles/s41586-022-05398-2.pdf", "https://www.ema.europa.eu/en/documents/public-statement/etf-statement-loss-activity-anti-spike-protein-monoclonal-antibodies-due-emerging-sars-cov-2_en.pdf", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552", "https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf", "https://www.herbalgram.org/media/17794/032223.pdf", "https://www.frontiersin.org/articles/10.3389/fmed.2022.1023507/pdf", "https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf", "https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf", "https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf", "https://www.nejm.org/doi/10.1056/NEJMc2209306", "https://jamanetwork.com/journals/jama/fullarticle/2797483", "https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-022-02547-2.pdf", "https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00663-6.pdf", "https://www.scienceopen.com/document_file/3455a93b-637b-4964-8372-8a06712968c6/PubMedCentral/3455a93b-637b-4964-8372-8a06712968c6.pdf", "https://www.nejm.org/doi/10.1056/NEJMc2209306", "https://jamanetwork.com/journals/jama/fullarticle/2797483", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057", "https://www.bmj.com/content/bmj/379/bmj-2022-073070.full.pdf", "https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/204/105", "https://jamanetwork.com/journals/jama/fullarticle/2797418?utm_source=substack&utm_mediu", "https://www.bmj.com/content/379/bmj.o2422?utm_source=substack&utm_medium=email", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500085/pdf/main.pdf", "https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(22)00480-7.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/pdf/main.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true", "https://cancer.jmir.org/2022/4/e35310/PDF", "https://mgyf.org/wp-content/uploads/2022/11/MGYF2022_046-1.pdf", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796667?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092622", "https://academic.oup.com/cid/article-pdf/75/Supplement_1/S61/45407502/ciac397.pdf", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797179", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575390/pdf/aim-olf-M221856.pdf", "https://bmjmedicine.bmj.com/content/bmjmed/1/1/e000297.full.pdf", "https://onlinelibrary.wiley.com/doi/pdf/10.1002/pmrj.12890", "https://www.thelancet.com/action/showPdf?pii=S2589-5370%2822%2900354-6", "https://www.frontiersin.org/articles/10.3389/fimmu.2022.1003094/pdf", "https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010799&type=printable", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true", "https://jamanetwork.com/journals/jamapediatrics/fullarticle/2790805", "https://jamanetwork.com/journals/jamapediatrics/fullarticle/2789414", "https://jamanetwork.com/journals/jama/fullarticle/2788986", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2209371?articleTools=true", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795998", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360656/pdf/10549_2022_Article_6693.pdf", "https://www.medicinabuenosaires.com/revistas/vol82-22/n5/659.pdf", "https://pubmed.ncbi.nlm.nih.gov/36053534/", "https://www.cmaj.ca/content/cmaj/194/33/E1155.full.pdf", "https://www.thelancet.com/action/showPdf?pii=S2666-5247%2822%2900127-6", "https://www.bmj.com/content/bmj/378/bmj-2022-071230.full.pdf", "https://jamanetwork.com/journals/jamadermatology/fullarticle/2792873", "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2791667", "https://www.nejm.org/doi/10.1056/NEJMc2205276", "https://neurologia.com/articulo/2022138", "https://www.medrxiv.org/content/10.1101/2022.09.25.22280341v2", "https://onlinelibrary.wiley.com/doi/epdf/10.1111/imj.15821?utm_source=substack&utm_medium=email", "https://bmjopen.bmj.com/content/bmjopen/12/8/e062945.full.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439627/pdf/cir-146-802.pdf", "https://www.bmj.com/content/bmj/378/bmj-2022-071245.full.pdf", "https://www.bmj.com/content/bmj/378/bmj.o1822.full.pdf", "https://www.nature.com/articles/s41598-022-19537-2.pdf", "https://www.cell.com/action/showPdf?pii=S2666-3791%2822%2900271-3", "https://www.ahajournals.org/doi/epdf/10.1161/CIRCULATIONAHA.122.059970", "https://www.onlinejcf.com/action/showPdf?pii=S1071-9164%2822%2900536-X", "https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2356", "https://www.bmj.com/content/bmj/378/bmj-2022-071416.full.pdf", "https://www.bmj.com/content/bmj/376/bmj.o117.full.pdf", "https://revistas.udea.edu.co/index.php/iatreia/article/view/346608/20807098", "https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf", "https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/original_7760.pdf", "https://jamanetwork.com/journals/jama/fullarticle/2794072", "https://alz.confex.com/alz/2022/meetingapp.cgi/Paper/66868", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201662?articleTools=true", "https://www.cureus.com/articles/103631-association-of-homologous-and-heterologous-vaccine-boosters-with-sars-cov-2-infection-in-bbibp-corv-vaccinated-healthcare-personnel", "https://link.springer.com/content/pdf/10.1007/s10787-022-01027-6.pdf", "http://iaes.edu.ve/iaespro/ojs/index.php/bmsa/article/view/494/681", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2208343?articleTools=true", "https://academic.oup.com/humrep/article/37/Supplement_1/deac105.038/6619730", "https://www.ajog.org/action/showPdf?pii=S0002-9378%2822%2900515-4", "https://journals.asm.org/doi/epdf/10.1128/mbio.01822-22", "https://www.bmj.com/content/bmj/378/bmj-2022-071249.full.pdf", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257064/pdf/bmj-2022-071502.pdf", "https://secure.medicalletter.org/downloads/1621g_table.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2210813?articleTools=true", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2794318", "https://www.cmaj.ca/content/cmaj/194/28/E969.full.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2203209?articleTools=true", "https://www.esteve.org/capitulos/social-impact-of-the-clinical-trials-on-covid-19-related-vaccines-and-other-drugs-2/", "https://www.nejm.org/doi/pdf/10.1056/NEJMc2210546?articleTools=true", "https://www.medsafe.govt.nz/safety/Alerts/nuvaxovid-myocarditis.asp", "https://www.thelancet.com/action/showPdf?pii=S2665-9913%2822%2900190-4", "https://www.gastrojournal.org/action/showPdf?pii=S0016-5085%2822%2900450-4", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181327/pdf/jcm-11-03042.pdf", "https://www.science.org/doi/epdf/10.1126/sciadv.abm7201", "https://www.nature.com/articles/s41421-022-00435-w.pdf", "https://www.science.org/doi/epdf/10.1126/sciimmunol.add4853", "https://www.acpjournals.org/doi/10.7326/M22-1425", "https://evidence.nejm.org/doi/pdf/10.1056/EVIDoa2200145", "https://www.researchsquare.com/article/rs-1749502/v1", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082071/pdf/fped-10-881765.pdf", "https://journals.lww.com/transplantjournal/Fulltext/2022/07000/A_Fourth_Dose_of_COVID_19_Vaccine_Does_Not_Induce.22.aspx", "https://www.nejm.org/doi/pdf/10.1056/NEJMra2206573?articleTools=true", "https://dtb.bmj.com/content/dtb/60/5/73.full.pdf", "https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001083", "https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S021392512200137X", "https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122000582", "https://www.elsevier.es/es-revista-piel-formacion-continuada-dermatologia-21-pdf-S0213925122001381", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037186/pdf/bjgpjul-2022-72-720-butler-fl-oa-p.pdf", "https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900163-1", "https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/1292/1037", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13103/10836", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11880/10858", "https://www.journalofinfection.com/action/showPdf?pii=S0163-4453%2822%2900248-1", "https://www.nature.com/articles/s41598-022-13920-9", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00426-1/fulltext", "https://www.medicinabuenosaires.com/revistas/vol82-22/destacado/casuistica_7802.pdf", "https://www.thelancet.com/action/showPdf?pii=S2213-8587%2822%2900158-9", "http://www.minerva-ebm.be/FR/GetPdf/2306?articleId=2262", "https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.19163", "https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full", "https://www.thelancet.com/action/showPdf?pii=S2213-2600%2822%2900186-2", "https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(22)00427-3.pdf", "https://www.cell.com/cell-reports-medicine/pdf/S2666-3791(22)00248-8.pdf", "https://www.bmj.com/content/370/bmj.m2980#:~:text=Conclusions,patients%20with%20severe%20covid%2D19", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288143/pdf/main.pdf", "https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9", "https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15350", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac496/6611663?login=false", "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2793109", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757475/pdf/KGMI_14_2018899.pdf", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac446/6603291?login=false", "https://www.journalofhospitalinfection.com/action/showPdf?pii=S0195-6701%2822%2900108-6", "https://www.frontiersin.org/articles/10.3389/fneur.2022.904796/full", "https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v1", "https://www.actasdermo.org/es-pdf-S0001731022001600", "https://www.actasdermo.org/es-pdf-S0001731022004124", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201300?articleTools=true", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155183/", "https://www.medsafe.govt.nz/profs/PUArticles/June2022/Targeting-SARs-CoV-2-Overview-COVID-19-treatments.html", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2792068", "https://www.thelancet.com/action/showPdf?pii=S2468-1253%2822%2900166-2", "https://molmed.biomedcentral.com/track/pdf/10.1186/s10020-022-00483-8.pdf", "https://www.journalofhospitalinfection.com/article/S0195-6701(22)00078-0/fulltext#relatedArticles", "https://www.bmj.com/content/377/bmj-2022-069989", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118946", "https://www.sciencedirect.com/science/article/pii/S0037196322000051", "https://www.mdpi.com/2076-393X/10/4/594", "https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/11958/10756", "https://jamanetwork.com/journals/jama/fullarticle/2792524", "https://academic.oup.com/fampra/advance-article/doi/10.1093/fampra/cmac041/6585930?login=false", "https://journals.plos.org/plosmedicine/article/authors?id=10.1371/journal.pmed.1003991", "https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.763", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2205011", "https://journals.sagepub.com/doi/10.1177/00220345221102310", "https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2901185-0", "https://www.bmj.com/content/377/bmj.o977", "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791533", "https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3465", "https://dtb.bmj.com/content/dtb/60/5/73.full.pdf", "https://www.bmj.com/content/bmj/377/bmj-2022-069989.full.pdf", "https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7111e1-H.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true", "https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900176-1", "https://www.sciencedirect.com/science/article/pii/S0033350621004741?via%3Dihub", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788157/pdf/main.pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201570?articleTools=true", "https://www.science.org/doi/epdf/10.1126/scitranslmed.abn8543", "https://www.mdpi.com/1424-8247/15/3/377/htm", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2115869?articleTools=true", "https://www.sciencedirect.com/science/article/pii/S2213858722000444", "https://link.springer.com/content/pdf/10.1007/s10875-021-01158-5.pdf", "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362", "https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149655", "https://www.dovepress.com/getfile.php?fileID=79350", "https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2022-056492/185378/COVID-19-Associated-Croup-in-Children", "https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2822%2900120-9", "https://www.journal-of-hepatology.eu/article/S0168-8278(22)00234-3/pdf", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2202826?articleTools=true", "https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-paxlovid-drug-interactions-resource-5-6-22-v1.1.pdf", "https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2021-055505/185412/Durability-of-SARS-CoV-2-Antibodies-From-Natural", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2200674?articleTools=true", "https://www.nejm.org/doi/pdf/10.1056/NEJMoa2118691?articleTools=true", "https://www.boletinoficial.gob.ar/busquedaAvanzada/busquedaEspecial", "https://normas.gba.gob.ar/covid-19", "https://www.paho.org/es/actualizacion-semanal-covid-19-argentina", "https://www.campusvirtualsp.org/es/covid-19", "https://www.paho.org/arg/index.php?option=com_content&view=article&id=10430:coronavirus&Itemid=226", "https://bvsalud.org/vitrinas/es/post_vitrines/nuevo_coronavirus/", "https://espanol.cdc.gov/enes/coronavirus/2019-ncov/index.html", "https://espanol.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html", "tel:0810 333 4133", "mailto:farmaceuticos@colfarma.org.ar", "javascript:;", "https://www.colfarma.info/colfarma/", "https://www.colfarma.info/colfarma/institucional/", "https://www.colfarma.info/colfarma/institucional/quienes-somos/", "https://www.colfarma.info/colfarma/institucional/consejo-directivo/", "https://www.colfarma.info/colfarma/institucional/comisiones-internas/", "https://www.colfarma.info/colfarma/institucional/tribunal-de-disciplina/", "https://www.colfarma.info/colfarma/institucional/filiales/", "https://www.colfarma.info/colfarma/departamentos/", "https://www.colfarma.info/colfarma/tad/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/matricula/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/sistema-unificado-cat-a/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/mala-praxis/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/residuos-patogenicos/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/multas/", "https://www.colfarma.info/colfarma/cuota-social-y-servicios/lista-de-precios/", "https://www.colfarma.info/colfarma/nuevo-sistema-de-credencial-digital/", "https://www.colfarma.info/colfarma/relaciones-profesionales/", "https://www.colfarma.info/colfarma/relaciones-profesionales/tramites/", "https://www.colfarma.info/colfarma/relaciones-profesionales/legislacion/", "https://www.colfarma.info/colfarma/relaciones-profesionales/especialides-farmaceuticas/", "https://www.colfarma.info/colfarma/relaciones-profesionales/psicotropicos-y-estupefacientes/", "https://www.colfarma.info/colfarma/obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/adhesion/", "https://www.colfarma.info/colfarma/obras-sociales/listado-de-os-y-pagos/listado-de-obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/listado-de-os-y-pagos/listado-de-obras-sociales/estado-de-pagos-de-obras-sociales/", "https://www.colfarma.info/colfarma/prensa/boletines-electronicos/boletin-electronico-de-obras-sociales/", "https://www.colfarma.info/colfarma/obras-sociales/filiales/", "https://www.colfarma.info/colfarma/obras-sociales/centralizados/", "http://www.adminportal.cfpba.org.ar/logonportal/frmlogonportaleswebs.aspx?ReturnUrl=http://www.adminportal.cfpba.org.ar/farmaceuticos/DenunciaDrogueria.aspx", "https://www.colfarma.info/colfarma/cientifica/", "https://www.colfarma.info/colfarma/cientifica/deap/otras-actividades-cientificas-2/", "https://www.colfarma.info/colfarma/cientifica/nanofarmacia/", "https://www.colfarma.info/colfarma/cientifica/laboratorio-ccbppf/", "https://www.colfarma.info/colfarma/cientifica/deap/", "https://www.colfarma.info/colfarma/material_de_consulta_bppf/", "https://www.colfarma.info/colfarma/relaciones-profesionales/oficina-de-denuncias/", "https://www.colfarma.info/colfarma/asuntos-laborales/", "https://www.colfarma.info/colfarma/simuladores-on-line/", "https://www.colfarma.info/colfarma/oportunidades-profesionales/", "https://www.colfarma.info/colfarma/asuntos-laborales/remuneraciones-farmaceuticas/", "https://www.colfarma.info/colfarma/herramientas-para-colegas/", "https://www.colfarma.info/colfarma/comision-provincial-de-asuntos-laborales-cpalpba/", "https://www.colfarma.info/colfarma/observatorio-laboral-farmaceutico/", "https://www.colfarma.info/colfarma/biblioteca/", "https://www.colfarma.info/colfarma/cientifica/rpvf/", "https://www.colfarma.info/colfarma/biblioteca/cimf/", "https://www.colfarma.info/colfarma/material_de_consulta_bppf/", "https://www.colfarma.info/colfarma/biblioteca/catalogo-bibliografico/", "https://www.colfarma.info/colfarma/biblioteca/publicaciones-cientificas-2/", "https://www.colfarma.info/colfarma/biblioteca/4915-2/", "https://www.colfarma.info/colfarma/subsidios/", "https://www.colfarma.info/colfarma/hospital/", "https://www.colfarma.info/colfarma/industria-y-drogueria/", "https://www.colfarma.info/colfarma/deportes/", "https://www.colfarma.info/colfarma/prensa/", "https://www.colfarma.info/colfarma/prensa/boletines-electronicos/", "https://www.colfarma.info/colfarma/prensa/comunicados-de-prensa/", "https://www.colfarma.info/colfarma/prensa/campanas-de-difusion/", "https://www.colfarma.info/colfarma/prensa/boletin-farmaceutico-bonaerense/", "https://www.colfarma.info/colfarma/noticias/"]}